書籍詳細

I章

P.3 掲載の参考文献

• 1) 小山恒男, 若槻俊之, 友利彰寿 他 : 【食道癌の発育進展-初期浸潤の病態と診断】食道粘膜癌の初期浸潤像の診断 拡大内視鏡の立場から. 胃と腸 47 (9) : 1360-1368, 2012

• 2) 小山恒男, 門馬久美子, 幕内博康 他 : 【[必携] 内視鏡リファレンスブック 2012】食道 食道扁平上皮癌の拡大内視鏡診断 日本食道学会分類の紹介. 消化器内視鏡 24 (4) : 466-468, 2012

P.4 掲載の参考文献

• 3) Sharma P, Meining AR, Coron E et al : Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy : final results of an international multicenter, prospective, randomized, controlled trial. Gastrointestinal endoscopy 74 (3) : 465-472, 2011
  pubmed

• 4) Gaddam S, Mathur SC, Singh M et al : Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 106 (11) : 1961-1969, 2011
  pubmed

• 5) Ishihara R, Inoue T, Hanaoka N et al : Autofluorescence imaging endoscopy for screening of esophageal squamous mucosal high-grade neoplasia : a phase II study. J Gastroenterol Hepatol 27 (1) : 86-90, 2012
  pubmed

• 6) Umeoka S, Okada T, Daido S et al : "Early esophageal rim enhancement" : A new sign of esophageal cancer on dynamic CT. Eur J Radiol 82 (3) : 459-463, 2013
  pubmed

• 7) Tixier F, Hatt M, Le Rest CC et al : Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53 (5) : 693-700, 2012

• 8) Aoyagi T, Shuto K, Okazumi S et al : Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28 (4) : 252-257, 2011
  pubmed

P.5 掲載の参考文献

• 9) 上里昌也, 赤井崇, 堀部大輔 他 : 食道内視鏡的粘膜下層剥離術におけるクリップ牽引法の有効性. 千葉医学雑誌 87 (6) : 237-243, 2011

• 10) Machida H, Tominaga K, Minamino H et al : Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. Endoscopy 44 (6) : 622-625, 2012
  pubmed

• 11) Bergman JJ, Zhang YM, He S et al : Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastro Endosc 74 (6) : 1181-1190, 2011

• 12) Ando N, Kato H, Igaki H et al : A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19 (1) : 68-74, 2012

• 13) Sjoquist KM, Burmeister BH, Smithers BM et al : Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma : an updated meta-analysis. Lancet Oncol 12 (7) : 681-692, 2011
  pubmed

• 14) Yokota T, Hatooka S, Ura T et al : Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer. Anticancer Res 31 (10) : 3535-3541, 2011
  pubmed

• 15) Ferri LE, Ades S, Alcindor T et al : Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma : a multicenter phase II trial. Ann Oncol 23 (6) : 1512-1517, 2012
  pubmed

P.6 掲載の参考文献

• 16) Tamura S, Imano M, Takiuchi H et al : Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403). Anticancer Res 32 (4) : 1403-1408, 2012
  pubmed

• 17) Eisterer W, DE Vries A, Kendler D et al : Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study. Anticancer Res 31 (12) : 4407-4412, 2011
  pubmed

• 18) Adelstein DJ, Rodriguez CP, Rybicki LA et al : A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs 30 (4) : 1684-1689, 2012

• 19) Tomblyn MB, Goldman BH, Thomas CR Jr et al : Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer : a phase-II study of the SWOG (S0414). J Thorac Oncol 7 (5) : 906-912, 2012
  pubmed

• 20) Schmitt JM, Sommers SR, Fisher W et al : Sunitinib plus paclitaxel in patients with advanced esophageal cancer : a phase II study from the Hoosier Oncology Group. J Thorac Oncol 7 (4) : 760-763, 2012

• 21) Hurt CN, Nixon LS, Griffiths GO et al : SCOPE1 : a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC cancer 11 : 466, 2011
  pubmed

• 22) Yuasa Y, Seike J, Yoshida T et al : Sentinel lymph node biopsy using intraoperative indocyanine green fluorescence imaging navigated with preoperative CT lymphography for superficial esophageal cancer. Ann Surg Oncol 19 (2) : 486-493, 2012

• 23) Dantoc M, Cox MR, Eslick GD : Evidence to support the use of minimally invasive esophagectomy for esophageal cancer : a meta-analysis. Arch Surg 147 (8) : 768-776, 2012
  pubmed

P.7 掲載の参考文献

• 24) Tsujimoto H, Takahata R, Nomura S et al : Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery 151 (5) : 667-673, 2012
  pubmed

• 25) Kinjo Y, Kurita N, Nakamura F et al : Effectiveness of combined thoracoscopiclaparoscopic esophagectomy : comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 26 (2) : 381-390, 2012
  pubmed

• 26) Cerfolio RJ, Bryant AS, Hawn MT : Technical aspects and early results of robotic esophagectomy with chest anastomosis. J Thorac Cardiovasc Surg 145 (1) : 90-96, 2013
  pubmed

• 27) Suda K, Ishida Y, Kawamura Y et al : Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position : technical report and short-term outcomes. World J Surg 36 (7) : 1608-1616, 2012
  pubmed

• 28) Kono K, Iinuma H, Akutsu Y et al : Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med 10 : 141, 2012
  pubmed

• 29) Ohki S, Shibata M, Gonda K et al : Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer. Oncol Rep 28 (2) : 453-458, 2012
  pubmed

• 30) Akutsu Y, Yasuda S, Nagata M et al : A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus. J Surg Oncol 105 (8) : 750-755, 2012

P.8 掲載の参考文献

• 1) Tsuboi K, Hoshino M, Sundaram A et al : Role of the lower esophageal sphincter on esophageal acid exposure-a review of over 2000 patients. Trop Gastroenterol 33 : 107-111, 2012
  pubmed

• 2) Chan WW, Haroian LR, Gyawali CP : Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 25 : 2943-2949, 2011
  pubmed

P.9 掲載の参考文献

• 3) 日本内視鏡外科学会学術委員会 : 内視鏡外科手術に関するアンケート調査-第11回集計結果報告-. 日鏡外会誌 17 (5) : 571-694, 2012

• 4) Ma S, Qian B, Shang L et al : A meta-analysis comparing laparoscopic partial versus Nissen fundoplication. ANZ J Surg 82 (1-2) : 17-22, 2012

• 5) Broeders JA, Roks DJ, Jamieson GG et al : Five-year outcome after laparoscopic anterior partial versus Nissen fundoplication : four randomized trials. Ann Surg 255 (4) : 637-642, 2012
  pubmed

• 6) Broeders JA, Bredenoord AJ, Hazebroek EJ et al : Reflux and belching after 270 degree versus 360 degree laparoscopic posterior fundoplication. Ann Surg 255 : 59-65, 2012
  pubmed

• 7) Mucio M, Rojano M, Herrera JJ et al : Novel surgical concept in antireflux surgery : long-term outcomes comparing 3 different laparoscopic approaches. Surgery 151 : 84-93, 2012
  pubmed

P.10 掲載の参考文献

• 8) Aye RW, Swanstrom LL, Kapur S et al : A randomized multiinstitution comparison of the laparoscopic Nissen and Hill repairs. Ann Thorac Surg 94 : 951-957, 2012
  pubmed

• 9) Pfluke JM, Parker M, Bowers SP et al : Use of mesh for hiatal hernia repair : a survey of SAGES members. Surg Endosc 26 : 1843-1848, 2012
  pubmed

• 10) Yigit T, Coskun AK, Sinan H et al : Rectus abdominus fascial sheath usage for crural reinforcement during surgical management of GERD : preliminary report of a prospective randomized clinical trial. Surg Laparosc Endosc Percutan Tech 22 : 333-337, 2012
  pubmed

• 11) Jarral OA, Athanasiou T, Hanna GB et al : Is an intra-oesophageal bougie of use during Nissen fundoplication? Interact Cardiovasc Thorac Surg 14 : 828-833, 2012
  pubmed

• 12) Stefanidis D, Hope WW, Kohn GP et al : Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24 : 2647-2669, 2010
  pubmed

• 13) Wilshire CL, Niebisch S, Watson TJ et al : Dysphagia postfundoplication : more commonly hiatal outflow resistance than poor esophageal body motility. Surgery 152 : 584-592, 2012
  pubmed

• 14) Juhasz A, Sundaram A, Hoshino M et al : Endoscopic assessment of failed fundoplication : a case for standardization. Surg Endosc 25 : 3761-3766, 2011
  pubmed

P.11 掲載の参考文献

• 15) Hoshino M, Srinivasan A, Mittal SK : High-resolution manometry patterns of lower esophageal sphincter complex in symptomatic post-fundoplication patients. J Gastrointest Surg 16 : 705-714, 2012
  pubmed

• 16) Juhasz A, Sundaram A, Hoshino M et al : Outcomes of surgical management of symptomatic large recurrent hiatus hernia. Surg Endosc 26 : 1501-1508, 2012
  pubmed

• 17) 日本食道学会 編 : "食道アカラシア取扱い規約 第4版", 金原出版, pp3-21, 2012

• 18) Muller M, Eckardt AJ, Gopel B et al : Clinical and manometric course of nonspecific esophageal motility disorders. Dig Dis Sci 57 : 683-689, 2012
  pubmed

• 19) Stefamidis D, Richardson W, Farrell TM et al : SAGES guidelines for the surgical treatment of esophageal achalasia. Surg Endosc 26 : 296-311, 2012

• 20) Katzka DA, Castell DO : Review article : an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther 34 : 832-839, 2011
  pubmed

• 21) Inoue H, Minami H, Kobayashi Y et al : Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42 : 265-271, 2010
  pubmed

P.12 掲載の参考文献

• 22) Swanstrom LL, Kurian A, Dunst CM et al : Long-Term Outcomes of an Endoscopic Myotomy for Achalasia : The POEM Procedure. Ann Surg 256 : 659-667, 2012
  pubmed

• 23) Mayo D, Griffiths EA, Khan OA et al : Does the addition of a fundoplication improve outcomes for patients undergoing laparoscopic Heller's cardiomyotomy? Int J Surg 10 : 301-304, 2012

• 24) Rawlings A, Soper NJ, Oelschlager B et al : Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia : results of a multicenter, prospective, randomized-controlled trial. Surg Endosc 26 : 18-26, 2012
  pubmed

• 25) Carter JT, Nguyen D, Roll GR et al : Predictors of long-term outcome after laparoscopic esophagomyotomy and Dor fundoplication for achalasia. Arch Surg 146 : 1024-1028, 2011
  pubmed

• 26) Wuller C, Bessell JR, Watson DI : Chest pain before and after laparoscopic cardiomyotomy for achalasia. ANZ J Surg 81 : 590-594, 2011
  pubmed

• 27) Wang Z, Zheng Q, Jin Z : Meta-analysis of robot-assisted versus conventional laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. ANZ J Surg 82 : 112-117, 2012
  pubmed

P.13 掲載の参考文献

• 28) Shaligram A, Unnirevi J, Simorov A et al : How does the robot affect outcomes? A retrospective review of open, laparoscopic, and robotic Heller myotomy for achalasia. Surg Endosc 26 : 1047-50, 2012,
  pubmed

• 29) Frazzoni M, Conigliaro R, Colli G et al : Conventional versus robot-assisted laparoscopic Nissen fundoplication : a comparison of postoperative acid reflux parameters. Surg Endosc 26 : 1675-1681, 2012
  pubmed

• 30) Storz P, Buess GF, Kunert W et al : 3D HD versus 2D HD : surgical task efficiency in standardised phantom tasks. Surg Endosc 26 : 1454-1460, 2012
  pubmed

P.14 掲載の参考文献

• 1) Jiang X, Hiki N, Nunobe S et al : Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107 : 275-279, 2012
  pubmed

• 2) Han DS, Suh YS, Kong SH et al : Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 30 : 3834-3840, 2012
  pubmed

• 3) Ahn HS, Shin YS, Park PJ et al : Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer 106 : 733-739, 2012
  pubmed

P.15 掲載の参考文献

• 4) Terashima M, Kitada K, Ochiai A et al : Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res 18 : 5992-6000, 2012
  pubmed

• 5) Kim HI, Hyung WJ, Song KJ et al : Oral vitamin B12 replacement : an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol 18 : 3711-3717, 2011
  pubmed

• 6) Kim JW, Cheong JH, Hyung WJ et al : Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 18 : 49-54, 2012
  pubmed

P.16 掲載の参考文献

• 7) Vinuela EF, Gonen M, Brennan MF et al : Laparoscopic versus open distal gastrectomy for gastric cancer : a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 255 : 446-456, 2012
  pubmed

• 8) Gordon AC, Kojima K, Inokuchi M et al : Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer. Surg Endosc 27 : 462-470, 2013
  pubmed

• 9) Park do J, Han SU, Hyung WJ et al : Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer : a large-scale multicenter retrospective study. Surg Endosc 26 : 1548-1553, 2012
  pubmed

• 10) Kanaya S, Kawamura Y, Kawada H et al : The delta-shaped anastomosis in laparoscopic distal gastrectomy : analysis of the initial 100 consecutive procedures of intracorporeal gastroduodenostomy. Gastric Cancer 14 : 365-371, 2011
  pubmed

• 11) Imamura H, Takiguchi S, Yamamoto K et al : Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg 36 : 632-637, 2012
  pubmed

• 12) Takiguchi S, Yamamoto K, Hirao M et al : A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer : results from a multi-institutional RCT. Gastric Cancer 15 : 198-205, 2012
  pubmed

P.17 掲載の参考文献

• 13) Lee MS, Ahn SH, Lee JH et al : What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc 26 : 1539-1547, 2012
  pubmed

• 14) Nagasako Y, Satoh S, Isogaki J et al : Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer. Br J Surg 99 : 849-854, 2012
  pubmed

• 15) Woo Y, Hyung WJ, Pak KH et al : Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg 146 : 1086-1092, 2011
  pubmed

• 16) Park SS, Kim MC, Park MS et al : Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons. Surg Endosc 26 : 60-67, 2012
  pubmed

• 17) Nunobe S, Hiki N, Gotoda T et al : Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer 15 : 338-342, 2012
  pubmed

P.18 掲載の参考文献

• 18) Fujita J, Kurokawa Y, Sugimoto T et al : Survival benefit of bursectomy in patients with resectable gastric cancer : interim analysis results of a randomized controlled trial. Gastric Cancer 15 : 42-48, 2012
  pubmed

• 19) Chang YR, Han DS, Kong SH, et al : The value of palliative gastrectomy in gastric cancer with distant metastasis. Ann Surg Oncol 19 : 1231-1239, 2012

• 20) Chang JS, Lim JS, Noh SH et al : Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer : implications for postoperative radiotherapy. Radiother Oncol 104 : 367-373, 2012
  pubmed

P.19 掲載の参考文献

• 21) An JY, Kim KM, Kim YM et al : Surgical complications in gastric cancer patients preoperatively treated with chemotherapy : their risk factors and clinical relevance. Ann Surg Oncol 19 : 2452-2458, 2012

• 22) Fujiwara Y, Takiguchi S, Nakajima K et al : Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol 18 : 3726-3731, 2011
  pubmed

• 23) Sasako M, Sakuramoto S, Katai H et al : Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29 : 4387-4393, 2011
  pubmed

• 24) Bang YJ, Kim YW, Yang HK et al : Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC) : a phase 3 open-label, randomised controlled trial. Lancet 379 : 315-321, 2012
  pubmed

P.20 掲載の参考文献

• 1) Musumba C, Jorgensen A, Sutton L et al : The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease : observation from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 36 : 48-56, 2012

• 2) Laine L, Kivitz AJ, Bello AE et al : Double-blind randomized trials of singletablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers. Am J Gastroenterol 107 : 379-386, 2012
  pubmed

P.21 掲載の参考文献

• 3) Sugano K, Kontani T, Katsuo S et al : Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy : results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trail. J Gastroenterol 47 : 540-552, 2012
  pubmed

• 4) Sanuki T, Fujita T, Kutsumi H et al : Rabeprazole reduce the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease : a prospective randomized active-controlled trial. J Gastroenterol 47 : 1186-1197, 2012
  pubmed

• 5) Tanikawa C, Urabe Y, Matsuo K et al : A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet 44 : 430-434, 2012
  pubmed

• 6) Schottker B, Adamu MA, Weck MN et al : Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol 10 : 487-493, 2012

P.22 掲載の参考文献

• 7) Gisbert JP, Calvet X, Cosme A et al : Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol 107 : 1197-1204, 2012
  pubmed

• 8) Sereni G, Azzolini F, Camellini L et al : Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol 18 : 4542-4548, 2012
  pubmed

• 9) McNicholl AG, Linares PM, Nyssen OP et al : Meta-analysis : esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 36 : 414-425, 2012
  pubmed

• 10) Federico A, Nardone G, Gravina AG et al : Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology 143 : 55-61, 2012
  pubmed

P.23 掲載の参考文献

• 11) Maehata Y, Nakamura S, Fujisawa K et al : Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 75 : 39-46, 2012
  pubmed

• 12) Nakamura S, Sugiyama T, Matsumoto T et al : Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori : a multicentre cohort follow-up study of 420 patients in Japan. Gut 61 : 507-513, 2012
  pubmed

• 13) Garcia-Iglesias P, Villoria A, Suarez D et al : Meta-analysis : predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther 34 : 888-900, 2011
  pubmed

• 14) Ljubicic N, Budimir I, Biscanin A et al : Endoclips vs large or small-volume epinephrine in peptic ulcer recurrent bleeding. World J Gastroenterol 18 : 2219-2224, 2012
  pubmed

• 15) Yen HH, Yang CW, Su PY et al : Use of hemostatic forceps as a preoperative rescue therapy for bleeding peptic ulcer. Surg Laparosc Endosc Percutan Tech 21 : 380-382, 2011
  pubmed

P.24 掲載の参考文献

• 16) Kuwabara K, Matsuda S, Fushimi K et al : Community-based evaluation of laparoscopic versus open simple closure of perforated peptic ulcers. World J Surg 35 : 2485-2492, 2012

• 17) Moran EA, Gostout CJ, McConico AL et al : Assessing the invasiveness of NOTES perforated viscus repair : a comparative study of NOTES and laparoscopy. Surg Endosc 26 : 103-109, 2012
  pubmed

• 18) Bonin EA, Moran E, Gostout CJ et al : Natural orifice transluminal endoscopic surgery for patients with perforated peptic ulcer. Surg Endosc 26 : 1534-1538, 2012
  pubmed

• 19) Lagergren J, Lindam A, Mason RM : Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study. Int J Cancer 131 : E1048-E1052, 2012

P.25 掲載の参考文献

• 1) D'Journo XB, Ouattara M, Loundou A et al : Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. Dis Esophagus 25 : 527-534, 2012
  pubmed

• 2) Derogar M, Orsini N, Sadr-Azodi O et al : Influence of major post operative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol 30 : 1615-1619, 2012

P.26 掲載の参考文献

• 3) Nishimura K, Tanaka T, Tsubuku T et al : Reflux esophagitis after esophagectomy : impact of duodenogastroesophageal reflux. Dis Esophagus 25 : 381-385, 2012
  pubmed

• 4) Yano M, Motoori M, Tanaka K et al : Prevention of gastroduodenal content reflux and delayed gastric emptying after esophagectomy : gastric tube reconstruction with duodenal diversion plus Roux-en-Y anastomosis. Dis Esophagus 25 : 181-187, 2012
  pubmed

• 5) Miyazaki T, Tanaka N, Hirai H et al : Ghrelin level and body weight loss after esophagectomy for esophageal cancer. J Surg Res 176 : 74-78, 2012
  pubmed

• 6) Koizumi M, Hosoya Y, Dezaki K et al : Postoperative weight loss does not resolve after esophagectomy despite normal serum ghrelin levels. Ann Thorac Surg 91 : 1032-1037, 2012

• 7) Biere SS, van Berge Henegouwen MI et al : Minimally invasive versus open oesophagectomy for patients with oesophageal cancer : a multicentre, openlabel, randomised controlled trial. Lancet 379 : 1887-1892, 2012
  pubmed

• 8) Mamidanna R, Bottle A, Hanna GB : Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England : a population-based national study. Ann Surg 255 : 197-203, 2012

P.27 掲載の参考文献

• 9) Yamada E, Shirakawa Y, Yamatsuji T et al : Jejunal interposition reconstruction with a stomach preserving esophagectomy improves postoperative weight loss and reflux symptoms for esophageal cancer patients. J Surg Res 178 : 700-707, 2012
  pubmed

• 10) Sultan J, Griffin SM, Di Franco F et al : Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99 : 346-355, 2012
  pubmed

P.28 掲載の参考文献

• 11) Dikic S, Randjelovic T, Dragojevic S et al : Early dumping syndrome and reflux esophagitis prevention with pouch reconstruction. J Surg Res 175 : 56-61, 2012
  pubmed

• 12) Ahn SH, Lee JH, Park DJ : Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer epub (doi : 10.1007/s10120-012-0178-x, 2012)

• 13) Katai H, Morita S, Saka M et al : Long-term outcome after proximal gastrectomy with jejunal interposition for suspected early cancer in the upper third of the stomach. Br J Surg 97 : 558-562, 2012

• 14) Namikawa T, Oki T, Kitagawa H et al : Impact of jejunal pouch interposition reconstruction after proximal gastrectomy for early gastric cancer on quality of life : short- and long-term consequences. Am J Surg 204 : 203-209, 2012

• 15) Takiguchi S, Yamamoto K, Hirao M et al : A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer : results from a multi-institutional RCT. Gastric Cancer 15 : 198-205, 2012
  pubmed

P.29 掲載の参考文献

• 16) Inokuchi M, Kojima K, Yamada H et al : Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy. Gastric Cancer 16 : 67-73, 2012
  pubmed

• 17) Lee MS, Ahn SH, Lee JH et al : What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc 26 (6) : 1539-1547, 2012
  pubmed

• 18) 杉山貢, 國崎主, 加藤広 他 : 胃切除後の骨代謝障害に対するアレンドロネートの有用性の検討. 日消外誌 44 : 361-373, 2012

• 19) Lim JS, Jin SH, Kim SB et al : Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy. J Clin Gastroenterol 46 : 669-674, 2012

• 20) Aoki T, Yamaji I, Hisamoto T et al : Irregular bowel movement in gastrectomized subjects : bowel habits, stool characteristics, fecal flora, and metabolites. Gastric Cancer 15 : 396-404, 2012
  pubmed

• 21) Tanaka K, Yano M, Motoori M et al : Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy : a prospective randomized controlled trial. Surgery 152 : 832-842, 2012
  pubmed

P.30 掲載の参考文献

• 22) Kim HI, Hyung WJ, Song KJ et al : Oral vitamin B12 replacement : an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol 18 : 3711-3717, 2012

P.31 掲載の参考文献

• 1) Buchwald H, William SE : Metabolic surgery worldwide 2003. Obes Surg 14 : 1157-1164, 2004
  pubmed

• 2) Buchwald H, Oien DM : Metabolic/bariatric surgery worldwide 2008. Obes Surg 19 : 1605-1611, 2009

• 3) Buchwald H, Oien DM : Metabolic/bariatric surgery worldwide 2011. Obes Surg 23 : 427-436, 2013
  pubmed

• 4) Franco JV, Ruiz PA, Palermo M et al : A review studies comparing three laparoscopic procedures in bariatric surgery : sleeve gastrectomy, Roux-en-Y gastric bypass and adjustablegastric banding. Obes Surg 21 : 1458-1468, 2011

P.32 掲載の参考文献

• 5) 北野正剛, 山下裕一, 白石憲男 他 : 日本内視鏡外科学会 内視鏡外科手術に関するアンケート調査 第10回集計結果報告. 日本内視鏡外科学会雑誌 17 (5) : 591-694, 2012

• 6) http://plaza.umin.ac.jp/~jsto/gakujyutsu/updata/statement_2010.pdf

P.33 掲載の参考文献

• 7) Regan JP, Inabnet WB, Gagner M et al : Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13 : 861-864, 2003
  pubmed

• 8) Eid GM, Brethauer S, Mattar SG et al : Laparoscopic sleeve gastrectomy for super obese patients : forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg 256 : 262-265, 2012
  pubmed

• 9) Rosenthal RJ ; International Sleeve Gastrectomy Expert Panel : International sleeve gastrectomy expert panel consensus statement : best practice guidelines based on experience of > 12,000 cases. Surg Obes Relat Dis 8 : 8-19, 2012

• 10) Jimenez A, Casamitjana R, Flores L et al : ong term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 256 : 1023-1029, 2012

• 11) Kasama K, Mui W, Lee WJ et al : IFSOAPC consensus statements 2011. Obes Surg 22 : 677-684, 2012
  pubmed

P.34 掲載の参考文献

• 12) Schauer PR, Kashyap SR, Wolski K et al : Bariatric surgery versus intensive medical therapy in obese patients with diabetes. NEJM 366 : 1567-1576, 2012.
  pubmed

• 13) Mingrone G, Panunzi S, De Gaetano A et al : Bariatric surgery versus intensive medical therapy for type 2 diabetes. NEJM 366 : 1577-1585, 2012

• 14) Ohta M, Kitano S, Kasama K et al : Results of anational survey on laparoscopic bariatric surgery in Japan, 2000-2009. Asian J Endosc Surg 4 : 138-142, 2011

• 15) Lee WJ, Chong K, Ser KH et al : Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus : a randomized controlled trial. Arch Surg 146 : 143-148, 2011
  pubmed

• 16) Lee WJ, Hur KY, Lakadawala M et al : Predicting success of metabolic surgery : age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis Aug 6, 2012 (doi : 10.1016/j.soard.2012.07.015)

• 17) 山本寛, 谷徹 : 現在の肥満外科治療の問題点. 成人病と生活習慣病 40 (3) : 288-294, 2010
  Medical*Online

P.35 掲載の参考文献

• 1) Fox J, Gross CP, Longo W et al : Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum 55 : 501-508, 2012
  pubmed

• 2) Vaid S, Tucker J, Bell T et al : Cost analysis of laparoscopic versus open colectomy in patients with colon cancer : results from a large nationwide population database. Am Surg 78 : 635-641, 2012
  pubmed

• 3) Surgical care and Outcomes Assessment Program (SCOAP) Collaborative, Billingham R, et al : Adoption of laparoscopy for elective colorectal resection : a report from the Surgical Care and Outcomes Assessment Program. J Am Coll Surg 214 : 909-918, 2012

P.36 掲載の参考文献

• 4) She WH, Poon JT, Fan JK et al : Outcome of laparoscopic colectomy for cancer in elderly patients. Surg Endosc 27 : 308-312, 2012
  pubmed

• 5) Hida K, Hasegawa S, Kinjo Y et al : Open versus laparoscopic resection of primary tumor for incurable stage IV colorectal cancer : a large multicenter consecutive patients cohort study. Ann Surg 255 : 929-934, 2012
  pubmed

• 6) Kim SJ, Ryu GO, Choi BJ et al : The short-term outcomes of conventional and single-port laparoscopic surgery for colorectal cancer. Ann Surg 254 : 933-940, 2011
  pubmed

• 7) Makino T, Milsom JW, Lee SW : Feasibility and safety of single-incision laparoscopic colectomy : a systematic review. Ann Surg 255 : 667-676, 2012
  pubmed

• 8) Park JS, Choi GS, Park SY et al : Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg 99 : 1219-1226, 2012
  pubmed

P.37 掲載の参考文献

• 9) Aarts MA, Okrainec A, Glicksman A et al : Adoption of enhanced recovery after surgery (ERAS) strategies for colorectal surgery at academic teaching hospitals and impact on total length of hospital stay. Surg Endosc 26 : 442-450, 2012
  pubmed

• 10) http://www.mhlw.go.jp/stf/shingi/2r9852000001u23a.html http://hospia.jp/dpc/

• 11) Henderson S, Morris AM, Zhang W et al : Early discharge and hospital readmission after colectomy for cancer. Dis Colon Rectum 54 : 1362-1367, 2011

• 12) Shapiro R, Vogel JD, Kiran RP : Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery : an additional benefit of the minimally invasive approach? Dis Colon Rectum 54 : 1496-1502, 2011
  pubmed

• 13) Masoomi H, Kang CY, Chen A et al : Predictive factors of in-hospital mortality in colon and rectal surgery. J Am Coll Surg 215 : 255-261, 2012
  pubmed

P.38 掲載の参考文献

• 14) West NP, Kobayashi H, Takahashi K et al : Understanding optimal colonic cancer surgery : comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30 : 1763-1769, 2012
  pubmed

• 15) Akiyoshi T, Watanabe T, Miyata S et al : Results of Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer : is it regional or distant disease? Ann Surg 255 : 1129-1134, 2012
  pubmed

• 16) McCahill LE, Yothers G, Sharif S et al : Primary mFOLFOX6 plus bevacizmab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer : definitive analysis of NSABP trial C-10. J Clin Oncol 30 : 3223-3228, 2012

P.39 掲載の参考文献

• 17) Abbott AM, Parsons HM, Tuttle TM et al : Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases : a population study. Ann Surg Oncol 20 : 139-147, 2013
  pubmed

• 18) Zhang Y, Shi J, Shi B et al : Self-expanding metallic stent sa a bridge to surgery versus emergency surgery for obstractive colorectal cancer : a meta-analysis. Surg Endosc 26 : 110-119, 2012

• 19) Lee WS, Baek JH, Kang JM et al : The outcome after stent placement or surgery as the initial treatment for obstructive primary tumor in patients with Stage IV colon cancer. Am J Surg 203 : 715-719, 2012
  pubmed

• 20) Parsons HM, Tuttle TM, Kunts KM et al : Association between lymphnode evaluation for colon cancer and node positivity over the past 20 years. JAMA 306 : 1089-1097, 2011

• 21) Sjo OH, Merok MA, Svindland A et al : Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55 : 307-315, 2012
  pubmed

• 22) Van der Zaag ES, Bouma WH, Tanis PJ et al : Systemic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol 19 : 3449-3459, 2012

P.40 掲載の参考文献

• 23) Yothers G, O'Connell MJ, Allegra DJ et al : Oxaliplatin as adjuvant therapy for colon cancer : updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29 : 3768-3774, 2011

• 24) Alberts SR, Sargent DJ, Nair S et al : Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer : a randomized trial. JAMA 307 : 1383-1393, 2012
  pubmed

• 25) Chang GJ, Kaiser AM, Mills S et al : Practice parameters for the management of colon cancer. Dis Colon Rectum 55 : 831-843, 2012
  pubmed

P.41 掲載の参考文献

• 1) Bonnetain F, Bosset JF, Gerard JP et al : What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials : surrogacy in question? Eur J Cancer 48 (12) : 1781-1790, 2012

• 2) Sauer R, Liersch T, Merkel S et al : Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer : results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30 (16) : 1926-1933, 2012
  pubmed

P.42 掲載の参考文献

• 3) Rodel C, Liersch T, Becker H et al : Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer : initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13 (7) : 679-687, 2012
  pubmed

• 4) Hofheinz RD, Wenz F, Post S et al : Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer : a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13 (6) : 579-588, 2012
  pubmed

• 5) Dewdney A, Cunningham D, Tabernero J et al : Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol 30 (14) : 1620-1627, 2012
  pubmed

• 6) Marechal R, Vos B, Polus M et al : Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer : a randomized multicentric phase II study. Ann Oncol 23 (6) : 1525-1530, 2011
  pubmed

P.43 掲載の参考文献

• 7) Martin ST, Heneghan HM, Winter DC : Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99 (7) : 918-928, 2012
  pubmed

• 8) Glynne-Jones R, Hughes R : Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg 99 (7) : 897-909, 2012
  pubmed

• 9) Maas M, Beets-Tan RG, Lambregts DM et al : Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29 (35) : 4633-4640, 2011
  pubmed

• 10) Perez RO, Habr-Gama A, Gama-Rodrigues J et al : Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation : long-term results of a prospective trial (National Clinical Trial 00254683). Cancer 118 (14) : 3501-3511, 2011
  pubmed

P.44 掲載の参考文献

• 11) Mezhir JJ, Shia J, Riedel E et al : Wholemount pathologic analysis of rectal cancer following neoadjuvant therapy : implications of margin status on long-term oncologic outcome. Ann Surg 256 (2) : 274-279, 2012
  pubmed

• 12) Govindarajan A, Gonen M, Weiser MR et al : Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29 (34) : 4568-4573, 2011
  pubmed

• 13) Smith FM, Chang KH, Sheahan K et al : The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg 99 (7) : 993-1001, 2012
  pubmed

P.45 掲載の参考文献

• 14) Trastulli S, Farinella E, Cirocchi R et al : Robotic resection compared with laparoscopic rectal resection for cancer : systematic review and meta-analysis of short-term outcome. Colorectal Dis 14 (4) : e134-156, 2012

• 15) Kim JY, Kim NK, Lee KY et al : A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer : laparoscopic versus robotic surgery. Ann Surg Oncol 19 (8) : 2485-2493, 2012

• 16) West NP, Kobayashi H, Takahashi K et al : Understanding optimal colonic cancer surgery : comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30 (15) : 1763-1769, 2012
  pubmed

P.46 掲載の参考文献

• 17) Fujita S, Akasu T, Mizusawa J et al : Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212) : results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13 (6) : 616-621, 2012
  pubmed

• 18) Akiyoshi T, Watanabe T, Miyata S et al : Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer : is it regional or distant disease? Ann Surg 255 (6) : 1129-1134, 2012
  pubmed

• 19) Ding P, Liska D, Tang P et al : Pulmonary recurrence predominates after combined modality therapy for rectal cancer : an original retrospective study. Ann Surg 256 (1) : 111-116, 2012
  pubmed

P.47 掲載の参考文献

• 1) Malgras B, Soyer P, Boudaf M et al : Accuracy of imaging for predicting operative approach in Crohn's disease. Br J Surg 99 : 1011-1020,

P.48 掲載の参考文献

• 2) Nanda K, Courtney W, Keegan D et al : Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn's disease. J Crohns Colitis, 2012 (doi : 10.1016/j.crohns.2012.07.019)

• 3) Watanabe T, Sasaki I, Sugita A et al : Time trend and risk factors for reoperation in Crohn's disease in Japan. Hepatogastroenterology 59 (116) : 1081-1086, 2012
  pubmed

• 4) Lee KY, Yu CS, Lee KY et al : Risk factors for repeat abdominal surgery in Korean patients with Crohn's disease : a multi-center study of a Korean inflammatory bowel disease study group. J Korean Soc Coloproctol, 2012 (doi : 10.3393/jksc.2012.28.4.188)

• 5) Kanazawa A, Yamana T, Okamoto K et al : Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease. Dis Colon Rectum 55 : 957-962, 2012
  pubmed

• 6) Bellolio F, Cohen Z, MacRae HM et al : Strictureplasty in selected Crohn's disease patients results in acceptable long-term outcome. Dis Colon Rectum 55 : 864-869, 2012
  pubmed

• 7) Campbell L, Ambe R, Weaver J et al : Comparison of conventional and nonconventional strictureplasties in Crohn's disease : a systematic review and meta-analysis. Dis Colon Rectum 55 (6) : 714-726, 2012
  pubmed

P.49 掲載の参考文献

• 8) 内視鏡外科手術に関するアンケート調査-第11回集計結果報告-. 日内視鏡外科会誌 17 (5) : 607-611, 2012

• 9) Rijcken E, Mennigen R, Senninger N et al : Single-port laparoscopic surgery for inflammatory bowel disease. Minim Invasive Surg, 2012 (doi : 10.1155/2012/106878)

• 10) Hung R, Valerian BT, Lee EC : Laparoscopic approach in patients with recurrent Crohn's disease. Am Surg 78 : 595-599, 2012

• 11) Ehteshami-Afshar S, Nikfar S, Rezaie A et al : A systemic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 7 (6) : 1000-1012, 2011

• 12) Waterman M, Xu W, Dinani A et al : Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut 62 (3) : 387-394, 2013
  pubmed

• 13) Papamichael K, Archavlis E, Lariou C et al : Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease : A prospective, two-year, single center, pilot study. J Crohns Colitis 6 : 924-931, 2012
  pubmed

• 14) Aguas M, Bastida G, Cerrillo E et al : Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 18 (32) : 4391-4398, 2012
  pubmed

• 15) Yoshida K, Fukunaga K, Ikeuchi H et al : Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection : A 3-year prospective randomized open trial. Inflamm Bowel Dis 18 (9) : 1617-1623, 2012
  pubmed

P.50 掲載の参考文献

• 16) Targownik LE, Singh H, Nugent Z et al : The epidemiology of colectomy in ulcerative colitis : results from a population-based cohort. Am J Gastroenterol 107 (8) : 1228-1235, 2012
  pubmed

• 17) 内野基, 池内浩基, 竹末芳生 他 : 潰瘍性大腸炎手術におけるSSIの検討. 日本腹部救急会誌 32 (6) : 1033-1039, 2012

• 18) Nisar PJ, Appau KA, Remzi FH et al : Preoperative hypoalbuminemia is associated with adverse outcomes after ileoanal pouch surgery. Inflamm Bowel Dis 18 (6) : 1034-1041, 2012
  pubmed

• 19) Powar MP, Martin P, Croft AR et al : Surgical outcomes in steroid refractory acute severe ulcerative colitis : The impact of rescue therapy. Colorectal Dis, 2012 (doi : 10.111/j.1463-1318.2012.03188.x.)

• 20) Kiely JM, Fazio VW, Remzi FH et al : Pelvic sepsis after IPAA adversely function of the pouch and quality of life. Dis Colon Rectum 55 (4) : 387-392, 2012
  pubmed

P.51 掲載の参考文献

• 21) Merrill A, Millham F : Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease : a study of National Surgical Quality Improvement Program patients. Arch Surg 147 (2) : 120-124, 2012
  pubmed

• 22) Miller AT, Berian JR, Rubin M et al : Robotic-assisted proctectomy for inflammatory bowel disease : a case-matched comparison of laparoscopic and robotic technique. J Gastrountest Surg 16 (3) : 587-594, 2012
  pubmed

• 23) Suzuki H, Ogawa H, Shibata C et al : The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum 55 : 330-336, 2012

• 24) 杉田昭, 池内浩基, 舟山裕士 他 : 潰瘍性大腸炎手術例の術後長期経過の検討-多施設共同研究による術後5年以上経過例の分析-. 日消誌 108 : 1996-2002, 2011
  Medical*Online

• 25) 河俣あゆみ, 内田恵一, 井上幹大 : 小児炎症性腸疾患で外科治療を受けた子どもに対するQOL評価-潰瘍性大腸炎で大腸全摘手術を受けた子供のQOL-. 小児保健研究 71 (5) : 731-736, 2012

P.52 掲載の参考文献

• 26) Kuruvilla K, Osler T, Hyman NH : A Comparison of the quality of life of ulcerative colitis patients after IPAA vs ileostomy. Dis Colon Rectum 55 : 1131-1137, 2012
  pubmed

P.53 掲載の参考文献

• 1) Ben Q, An W, Jiang Y et al : Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142 : 762-772, 2012
  pubmed

• 2) 佐藤友美, 野崎良一, 山田一隆 他 : 肥満と大腸腺腫発生部位との関連性. 人間ドック 26 (5) : 734-742, 2012
  Medical*Online

P.54 掲載の参考文献

• 3) Manser CN, Bachmann LM, Brunner J et al : Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death : a closed cohort study. Gastrointest Endosc 76 : 110-117, 2012

• 4) Zauber AG, Winawer SJ, O'Brien MJ et al : Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 : 687-696, 2012
  pubmed

• 5) Brenner H, Chang-Claude J, Rickert A et al : Risk of colorectal cancer after detection and removal of adenomas at colonoscopy : population-based casecontrol study. J Clin Oncol 30 : 2969-2976, 2012
  pubmed

• 6) Ikematsu H, Saito Y, Tanaka S et al : The impact of narrow band imaging for colon polyp detection : a multicenter randomized controlled trial by tandem colonoscopy. J Gastroenterol 47 : 1099-1107, 2012
  pubmed

P.55 掲載の参考文献

• 7) Jin XF, Chai TH, Shi JW et al : Meta-analysis for evaluating the accuracy of endoscopy with narrow band imaging in detecting colorectal adenomas. J Gastroenterol Hepatol 27 : 882-887, 2012
  pubmed

• 8) Leufkens AM, van Oijen MG, Vleggaar FP et al : Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy 44 : 470-475, 2012

• 9) Chiu HM, Lin JT, Lee YC et al : Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population. Dis Colon Rectum 54 : 1570-1577, 2011
  pubmed

• 10) Peng J, He Y, Xu J et al : Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans : results of a prospective study. Colorectal Dis 13 : e374-378, 2011

• 11) Hirakawa T, Kato J, Okumura Y et al : Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT). J Gastroenterol 47 : 127-135, 2012
  pubmed

• 12) Zalis ME, Blake MA, Cai W et al : Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults : a prospective evaluation. Ann Intern Med 156 : 692-702, 2012
  pubmed

P.56 掲載の参考文献

• 13) 中澤三郎, 乾和郎, 服部外志之 他 : CT colonographyの臨床的研究. 日本消化器がん検診学会雑誌 49 (6) : 1105-1113, 2011

• 14) Pohl H, Srivastava A, Bensen SP et al : Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 144 : 74-80, 2013
  pubmed

• 15) Burnett-Hartman AN, Newcomb PA, Phipps AI et al : Colorectal endoscopy, advanced adenomas, and sessile serrated polyps : implications for proximal colon cancer. Am J Gastroenterol 107 : 1213-1219, 2012
  pubmed

P.57 掲載の参考文献

• 16) Kobayashi N, Yoshitake N, Hirahara Y et al : Matched case-control study comparing endoscopic submucosal dissection and endoscopic mucosal resection for colorectal tumors. J Gastroenterol Hepatol 27 : 728-733, 2012
  pubmed

• 17) Terasaki M, Tanaka S, Oka S et al : Clinical outcomes of endoscopic submucosal dissection and endoscopic mucosal resection for laterally spreading tumors larger than 20 mm. J Gastroenterol Hepatol 27 : 734-740, 2012

• 18) Alderlieste YA, Rauws EA, Mathus-Vliegen EM et al : Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis. Fam Cancer 12 : 51-56, 2013
  pubmed

• 19) Bulow S, Christensen IJ, Hojen H et al : Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 14 : 947-952, 2012
  pubmed

P.58 掲載の参考文献

• 20) Bartels SA, D'hoore A, Cuesta MA et al : Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy : a cross-sectional study. Ann Surg 256 : 1045-1048, 2012

• 21) Tonelli F, Ficari F, Bargellini T et al : Ileal pouch adenomas and carcinomas after restorative proctocolectomy for familial adenomatous polyposis. Dis Colon Rectum 55 : 322-329, 2012
  pubmed

• 22) Banasiewicz T, Marciniak R, Kaczmarek E et al : The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP. Int J Colorectal Dis 26 : 1197-1203, 2011

• 23) Pioche M, Aguero Garcete G, Forestier J et al : Macroscopic and histologic regression of duodenal polyposis with FOLFOX4 chemotherapy for an ileal pouch adenocarcinoma in a patient with familial adenomatous polyposis. Endoscopy 44 : 1165-1167, 2012

P.59 掲載の参考文献

• 1) 大腸癌研究会 編 : リンチ症候群. "遺伝性大腸癌診療ガイドライン", 金原出版, pp31-73, 2012

P.60 掲載の参考文献

• 2) Steinhagen E, Shia J, Markowitz AJ et al : Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resection. J Am Coll Surg 214 : 61-67, 2012
  pubmed

• 3) van Lier MG, Leenen CH, Wagner A et al ; LIMO Study Group : Yield of routine molecular analyses in colorectal cancer patients <- 70 years to detect underlying Lynch syndrome. J Pathol 226 : 764-774, 2012

• 4) Warrier SK, Trainer AH, Lynch AC et al : Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54 : 1480-1487, 2011
  pubmed

• 5) Weissman SM, Burt R, Church J et al : Identification of individuals at risk for Lynch syndromeu sing targeted evaluations and genetic testing : National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Counsel 21 : 484-493, 2012

P.61 掲載の参考文献

• 6) Chubak B, Heald B, Sharp RR : Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome. Genet Med 13 : 356-360, 2011
  pubmed

• 7) Williams JL, Williams MS : Informed consent and immunohistochemistry screening for Lynch syndrome. Genet Med 13 : 848-849, 2011
  pubmed

• 8) Beamer LC, Grant ML, Espenschied CR et al : Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 30 : 1058-1063, 2012
  pubmed

• 9) Kastrinos F, Syngal S : Screening patients with colorectal cancer for Lynch syndrome : What are we waiting for? J Clin Oncol 30 : 1024-1027, 2012
  pubmed

• 10) Pritchard CC, Smith C, Salipante SJ et al : ColoSeq provides comprehensive Lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 14 : 357-366, 2012
  pubmed

P.62 掲載の参考文献

• 11) Monteiro Santos EM, Valentin MD, Carneiro F et al : Predictive models for mutations in mismatch repair genes : implication for genetic counseling in developing countries. BMC Cancer 12 : 64, 2012
  pubmed

• 12) Kastrinos F, Steyerberg EW, Balmana J et al : Colon Cancer Family Registry : Comparison of the clinical prediction model PREMM1, 2, 6 and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 62 : 272-279, 2013
  pubmed

• 13) Mercado RC, Hampel H, Kastrinos F et al : Colon Cancer Family Registry : Performance of PREMM1, 2, 6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 14 : 670-680, 2012
  pubmed

• 14) Bessa X, Alenda C, Paya A et al : Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. J Clin Oncol 29 : 3374-3380, 2011

P.63 掲載の参考文献

• 15) Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP et al : Quality of life after surgery for colon cancer in patients with Lynch syndrome : Partial versus subtotal colectomy. Dis Colon Rectum 55 : 653-659, 2012
  pubmed

• 16) Kalady MF, Lipman J, McGannon E et al : Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255 : 1121-1125, 2012
  pubmed

• 17) Win AK, Lindor NM, Young JP et al : Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst 104 : 1363-1372, 2012
  pubmed

• 18) Pande M, Wei C, Chen J et al : Cancer spectrum in DNA mismatch repair gene mutation carriers : Results from a hospital based Lynch syndrome registry. Fam Cancer 11 : 441-447, 2012

P.64 掲載の参考文献

• 19) Grandval P, Baert-Desurmont S, Bonnet F et al : Colon-specific phenotype in Lynch syndrome associated with EPCAM deletion. Clin Genet 82 : 97-99, 2012
  pubmed

• 20) Huth C, Kloor M, Voigt AY et al : The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Mod Pathol 25 : 911-916, 2012
  pubmed

P.65 掲載の参考文献

• 21) Francisco I, Albuquerque C, Lage P et al : Familial colorectal cancer type X syndrome : two distinct molecular entities? Fam Cancer 10 : 623-631, 2011
  pubmed

• 22) Koh PK, Kalady M, Skacel M et al : Familial colorectal cancer type X : polyp burden and cancer risk stratification via a family history score. ANZ J Surg 81 : 537-542, 2011

• 23) Burn J, Gerdes AM, Macrae F et al ; CAPP2 Investigators : Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer : An analysis from the CAPP2 randomised controlled trial. Lancet 17 : 2081-2087, 2011

• 24) Chan AT, Lippman SM : Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet 378 : 2051-2052, 2011
  pubmed

• 25) Cleland JG : Does aspirin really reduce the risk of colon cancer? Lancet 379 : 1586-1587, 2012
  pubmed

P.66 掲載の参考文献

• 26) Kloor M, Huth C, Voigt AY et al : Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome : a pathological study. Lancet Oncol 13 : 598-606, 2012
  pubmed

• 27) Boland CR : Lynch syndrome : New tales from the crypt. Lancet Oncol 13 : 562-564, 2012
  pubmed

• 28) de Miranda NF, Goudkade D, Jordanova ES et al : Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases. Clin Cancer Res 18 : 1237-1245, 2012
  pubmed

• 29) Winkels RM, Botma A, Van Duijnhoven FJ et al : Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology 142 : 241-247, 2012
  pubmed

P.67 掲載の参考文献

• 1) 矢野孝明, 野垣岳志, 浅野道雄 他 : 内痔核II度とIII度に対するALTA治療効果の比較検討. 臨床肛門病学 4 : 44-46, 2012

• 2) Infantino A, Altomare DF, Bottini C et al : Prospective randomized multicentre study comparing stapler haemorrhoidopexy with Doppler-guided transanal haemorrhoid dearterialization for third-degree haemorrhoids. Colorectal Dis 14 : 205-211, 2011

P.68 掲載の参考文献

• 3) Lewis R, Lunniss PJ, Hammond M : Novel biological strategies in the management of anal fistula. Colorectal Dis 14 : 1445-1455, 2012

• 4) Guadalajara H, Herreros D, De-La-Quintana P et al : Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27 : 595-600, 2012
  pubmed

• 5) Sajid MS, Whitehouse PA, Sains P et al : Systematic review of the use of topical diltiazem compared with glyceryltrinitrate for the non-operative management of chronic anal fissure. Colorectal Dis (doi : 10.1111/j.1463-1318.2012.03042.x)

• 6) Yiannakopoulou E : Botulinum toxin and anal fissure : Efficacy and safety systematic review. Int J Colorectal Dis 27 : 1-9, 2012
  pubmed

• 7) Magdy A, El Nakeeb A, Fouda el Y et al : Comparative study of conventional lateral internal sphincterotomy, V-Y anoplasty, and tailored lateral internal sphincterotomy with V-Y anoplasty in the treatment of chronic anal fissure. J Gastrointest Surg 16 : 1955-1962, 2012

P.69 掲載の参考文献

• 8) Ersoz F, Arikan S, Sari S et al : Type of lateral internal sphincterotomy incision : Parallel or vertical? World J Surg 35 : 1137-1141, 2011
  pubmed

• 9) Gee T, Hisham RB, Jabar MF et al : Anococcygeal support in the treatment of idiopathic chronic posterior anal fissure : a prospective non-randomized controlled pilot study. Tech Coloproctol (doi 10.1007/s10151-012-0894-6)

• 10) 小出欣和, 前田耕太郎, 花井恒一 他 : 直腸脱に対する直腸固定術の手技と成績. 日本大腸肛門病会誌 65 : 840-846, 2012

• 11) Formijne Jonkers HA, Draaisma WA, Wexner SD et al : Evaluation and surgical treatment of rectal prolapse : an international survey. Colorectal Dis (doi : 10.1111/j.1463-1318.2012.03135.x)

• 12) Wong M, Meurette G, Abet E et al : Safety and efficacy of laparoscopic ventral mesh rectopexy for complex rectocele. Colorectal Dis 13 : 1019-1023, 2011
  pubmed

• 13) van der Hagen SJ, van Gemert WG, Soeters PB et al : Transvaginal posterior colporrhaphy combined with laparoscopic ventral mesh rectopexy for isolated Grade III rectocele : a prospective study of 27 patients. Colorectal Dis 14 : 1398-1402, 2012
  pubmed

P.70 掲載の参考文献

• 14) Brandner SB, Monga A, Mueller MD et al : Sexual function after rectocele repair. J Sex Med 8 : 583-588, 2011

• 15) 味村俊樹, 山名哲郎, 高尾良彦 他 : 本邦における便失禁診療の実態調査報告-診断と治療の現状. 日本大腸肛門病会誌 65 : 101-108, 2012

• 16) 味村俊樹, 山名哲郎, 高尾良彦 他 : 本邦における便失禁診療の実態調査報告-仙骨神経刺激療法の適応に関する検討-. 日本大腸肛門病会誌 65 : 109-117, 2012

• 17) Mellgren A, Wexner SD, Coller JA et al : Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 54 : 1065-1076, 2011
  pubmed

• 18) George AT, Kalmar K, Panarese A et al : Long-term outcomes of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 55 : 302-306, 2012
  pubmed

• 19) Giani L, Novelli E, Marina S et al : The effect of sacral nerve modulation on cerebral evoked potential latency in fecal incontinence and constipation. Ann Surg 254 : 90-96, 2011

P.71 掲載の参考文献

• 1) Forner A, Llovet JM, Bruix J : Hepatocellular carcinoma. Lancet 379 1245-1255, 2012
  pubmed

P.72 掲載の参考文献

• 2) Hosaka T, Suzuki F, Kobayashi M et al : Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology, 2012 (doi : 10.1002/hep.26180)

• 3) Izumi N, Asahina Y, Kurosaki M et al : Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study. J Gastroenterol, 2012 (doi : 10.1007/s00535-012-0641-9)

• 4) Harada K, Hirohara J, Ueno Y et al : Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis : national data from Japan. Hepatology, 2012 (doi : 10.1002/hep.26176)

P.73 掲載の参考文献

• 5) Dohmen T, Kataoka E, Yamada I et al : Efficacy of contrast-enhanced ultra-sonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med 51 : 1-7, 2012

• 6) Shindoh J, Andreou A, Aloia TA et al : Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm : reappraisal of the staging system for solitary tumors. Ann Surg Oncol, 2012 (doi : 10.1245/s10434-012-2739-y)
  pubmed

• 7) Adam R, Bhangui P, Vibert E et al : Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver. Does size define the best oncological strategy? Ann Surg 256 : 883-891, 2012

P.74 掲載の参考文献

• 8) Arii S, Sata M, Sakamoto M et al : Management of hepatocellular carcinoma : report of consensus meeting in the 45th annual meeting of the Japan Society of Hepatology 2009. Hepatol Res 40 : 667-685, 2010

• 9) 日本肝臓学会 編 : "科学的根拠に基づく肝癌診療ガイドライン 2009年版", 金原出版, 東京, 2009

• 10) Rahbari NN, Garden OJ, Padbury R et al : Posthepatectomy liver failure : a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 : 713-724, 2011

• 11) Rahbari NN, Reissfelder C, Koch M et al : The predictive value of postoperative clinical risk scores for outcome after hepatic resection : a validation analysis in 807 patients. Ann Surg Oncol 18 : 3640-3649, 2011
  pubmed

• 12) Chen X, Zhai J, Cai X et al : Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg 99 : 1701-1710, 2012

P.75 掲載の参考文献

• 13) Yin Z, Fan X, Ye H et al : Short-and Long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma : a global systematic review and meta-analysis. Ann Surg Oncol, 2012 (doi : 10.1245/s10434-012-2705-8)

• 14) Shim JH, Han S, Lee YJ et al : Half-life of serum alpha-fetoprotein, an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma. Ann Surg, 2012 (doi : 10.1097/SLA.0b013e318273be70

P.76 掲載の参考文献

• 15) Schnitzbauer AA, Zuelke C, Graeb C et al : A prospective randomized, open-labeled, trial comparing sirolimus-containing versus mTOR inhibitor free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 10 : 190, 2010
  pubmed

• 16) Duvoux C, Thoraval FR, Decaens T et al : Liver transplantation for hepatocellular carcinoma : a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 143 : 986-994, 2012

P.77 掲載の参考文献

• 17) Burrel M, Reig M, Forner A et al : Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolization (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatology 56 : 1330-1335, 2012

• 18) Sato M, Tateishi R, Yasunaga H et al : Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma : a national survey of 54,145 patients. J Gastroenterol 47 : 1125-1133, 2012
  pubmed

P.78 掲載の参考文献

• 19) Bruix J, Raoul JL, Sherman M et al : Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : subanalyses of a phase III trial. J Hepatol 57 : 821-829, 2012
  pubmed

P.79 掲載の参考文献

• 1) Palmer WC, Patel T : Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57 : 69-76, 2012
  pubmed

• 2) Nordenstedt H, Mattsson F, El-Serag H et al : Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer 106 : 1011-1015, 2012
  pubmed

P.80 掲載の参考文献

• 3) Chong YS, Kim YK, Lee MW et al : Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Clin Radiol 67 : 766-773, 2012
  pubmed

• 4) Park HJ, Kim YK, Park MJ et al : Small intrahepatic mass-forming cholangiocarcinoma : target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging, 2012 (doi : 10.1007/s00261-012-9943-x)

• 5) Igami T, Ebata T, Yokoyama Y et al : Staging of peripheral-type intrahepatic cholangiocarcinoma : appraisal of the new TNM classification and its modifications. World J Surg 35 : 2501-2509, 2011
  pubmed

• 6) Farges O, Fuks D, Regimbeau JM et al : Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma : a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 254 : 824-829, 2011

• 7) Ribero D, Pinna AD, Guglielmi A et al : Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma : A Multi-Institutional Analysis of 434 Patients. Arch Surg 147 : 1107-1113, 2012
  pubmed

P.81 掲載の参考文献

• 8) Fisher SB, Patel SH, Kooby DA et al : Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma : a multi-institution analysis. HPB (Oxford) 14 : 514-522, 2012
  pubmed

• 9) Morine Y, Shimada M : Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42 : 147-151, 2012

• 10) Chen TC, Jan YY, Yeh TS : K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol 19 : S675-681, 2012

• 11) Gu FM, Gao Q, Shi GM et al : Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann Surg Oncol 19 : 2506-2514, 2012

• 12) Morine Y, Shimada M, Iwahashi S et al : Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. Surgery 15 : 412-419, 2012

• 13) Higashi M, Yamada N, Yokoyama S et al : Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology 79 : 101-106, 2012
  pubmed

• 14) Eckmann KR, Patel DK, Landgraf A et al : Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma : a retrospective analysis. Gastrointest Cancer Res 4 : 155-160, 2011
  pubmed

P.82 掲載の参考文献

• 15) XuH X, Wang Y, LuM D et al : Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol 85 : 1078-1084, 2012

• 16) Vogl TJ, Naguib NN, Nour-Eldin NE et al : Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma : Results and prognostic factors governing treatment success. Int J Cancer 131 : 733-740, 2012
  pubmed

• 17) Halappa VG, Bonekamp S, Corona-Villalobos CP et al : Intrahepatic cholangiocarcinoma treated with local-regional therapy : quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 264 : 285-294, 2012
  pubmed

• 18) Wu ZF, Zhang HB, Yang N et al : Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors : results of a large monocentric series. Eur J Surg Oncol 38 : 602-610, 2012
  pubmed

P.83 掲載の参考文献

• 1) Schnitzbauer AA, Lang SA, Goessmann H et al : Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255 : 405-414, 2012
  pubmed

P.84 掲載の参考文献

• 2) Tanaka K, Kumamoto T, Nojiri K et al : Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases. World J Surg 36 : 1832-1841, 2012
  pubmed

P.85 掲載の参考文献

• 3) Andres A, Toso C, Adam R et al : A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases : A LiverMetSurvey-Based Study. Ann Surg 256 : 772-779, 2012

P.86 掲載の参考文献

• 4) Spampinato MG, Mandala L, Quarta G et al : One-stage, totally laparoscopic major hepatectomy and colectomy for colorectal neoplasm with synchronous liver metastasis : Safety, feasibility and short-term outcome. Surgery, 2012 Jul 31 (doi : 10.1016/j.surg.2012.06.007)

P.87 掲載の参考文献

• 5) Di Fabio F, Whistance R, Rahman S et al : Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases. J Laparoendosc Adv Surg Tech A 22 : 647-650, 2012
  pubmed

• 6) Machado MA, Makdissi FF, Surjan RC : Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg ; 256 : e13 ; author reply e16-9, 2012

• 7) Chua TC, Saxena A, Liauw W et al : Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review. Eur J Cancer 48 : 1757-1765, 2012
  pubmed

P.88 掲載の参考文献

• 8) Weng M, Zhang Y, Zhou D et al : Radiofrequency ablation versus resection for colorectal cancer liver metastases : a meta-analysis. PLoS One 7 : e45493, 2012

P.89 掲載の参考文献

• 9) Gillams A, Khan Z, Osborn P et al : Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol 2012 Oct 17 (doi : 10.1007/s00270-012-0500-3)

• 10) Sorbye H, Mauer M, Gruenberger T et al : Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 255 : 534-539, 2012
  pubmed

P.90 掲載の参考文献

• 11) Nordlinger B, et al : Peri-operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer : Long-term survival results of the EORTC intergroup phase III study 40983. 2012 ASCO Abstract #3508

• 12) Nanji S, Cleary S, Ryan P et al : Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol, 2012 Oct 5 (doi : 10.1245/s10434-012-2424-1)

• 13) Saiura A, Yamamoto J, Hasegawa K et al : Liver resection for multiple colorectal liver metastases with surgery up-front approach : bi-institutional analysis of 736 consecutive cases. World J Surg 36 : 2171-2178, 2012
  pubmed

• 14) Andreou A, Kopetz S, Maru DM et al : Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256 : 642-650, 2012
  pubmed

P.92 掲載の参考文献

• 1) 日本肝癌研究会 編 : "原発性肝癌取扱い規約, 第5版補訂版", 金原出版, 東京, 2009

• 2) 日本肝癌研究会 編 : "第18回全国原発性肝癌追跡調査報告 (2004～2005)", 2009

P.93 掲載の参考文献

• 3) 北井聡, 工藤正俊 : 混合型肝癌の疫学 : 全国集計を中心に. 肝胆膵 63 : 559-563, 2011
  Medical*Online

• 4) 有泉俊一, 山本雅一 : 混合型肝癌における予後と治療. 肝胆膵 63 : 593-600, 2011
  Medical*Online

• 5) Yin X, Zhang BH, Qiu SJ, et al : Combined hepatocellular carcinoma and cholangiocarcinoma : clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19 : 2869-2876, 2012

P.94 掲載の参考文献

• 6) 宇都宮徹, 島田光生, 居村暁 他 : 原発性肝肉腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp276-280, 2010

• 7) 上村顕也, 須田剛士, 青柳豊 : 肝類上皮血管内皮腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp225-228, 2010

• 8) 山崎香奈, 趙成済, 桑鶴良平 : 類上皮性血管内皮腫epithelioid hemangioendotheliomaと肝表面の陥凹. 画像診断 32 : 94-95, 2012

• 9) Wang LR, Zhou JM, Zhao YM et al : Clinical experience with primary hepatic epithelioid hemangioendothelioma : Retrospective study of 33 patients. World J Surg 36 : 2677-2683, 2012
  pubmed

P.95 掲載の参考文献

• 10) 三浦智史, 高橋達 : 肝血管肉腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp283-286, 2010

• 11) 須納瀬豊, 平井圭太郎, 吉成大介 他 : 急性の肝破裂に対して緊急肝切除により救命しえた肝未分化肉腫の1例. 手術 65 : 381-384, 2011

• 12) 龍知記, 高見裕子, 立石昌樹 他 : 術後4年以上生存中の成人肝未分化肉腫の1例. 日本消化器外科学会雑誌 45 : 273-281, 2012

• 13) Noguchi K, Yokoo H, Nakanishi K et al : A long-term survival case of adult undifferentiated embryonal sarcoma of liver. World J Surg Oncol 2012 Apr 27 ; 10 : 65 (doi : 10.1186/1477-7819-10-65)

P.96 掲載の参考文献

• 14) 日本小児外科学会悪性腫瘍委員会 : 小児の外科的悪性腫瘍. 2010年登録症例の全国集計結果の報告. 日小外会誌 48 : 92-129, 2012
  Medical*Online

• 15) Hishiki T, Matsunaga T, Sasaki F et al : Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2 : Report from the JPLT. Pediatr Surg Int 27 : 1-8, 2011

P.97 掲載の参考文献

• 16) Wang YX, Liu H : Adult hepatoblastoma : Systemic review of the English literature. Dig Surg 29 : 323-330, 2012
  pubmed

• 17) 中島収 : 新WHO分類による肝細胞腺腫の位置づけと亜分類. 病理と臨床 30 : 230-231, 2012
  Medical*Online

• 18) Sasaki M, Nakanuma Y : Overview of hepatocellular adenoma in Japan. Int J Hepatol, 2012 (doi : 10.1155/2012/648131)

P.98 掲載の参考文献

• 19) Farges O, Ferreira N, Dokmak S et al : Changing trends in malignant trans-formation of hepatocellular adenoma. Gut 60 : 85-89, 2011

• 20) Noels JE, van Aalten SM, van der Windt DJ et al : Management of hepatocellular adenoma during pregnancy. J Hepatol 54 : 553-558, 2011
  pubmed

• 21) van Aalten SM, de Man RA, IJzermans JN et al : Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 99 : 911-916, 2012
  pubmed

P.99 掲載の参考文献

• 22) Kuroda T, Kumagai M, Nosaka S et al : Critical infantile hepatic hemangioma : results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group. J Pediatr Surg 46 : 2239-2243, 2011

• 23) Donati M, Stavrou GA, Donati A et al : The risk of spontaneous rupture of liver hemangiomas : a critical review of the literature. J Hepatobiliary Pancreat Sci 18 : 797-805, 2011
  pubmed

• 24) 田中基彦, 佐々木裕 : 限局性結節性過形成. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp141-145, 2010

• 25) Hanaoka J, Shimada M, Utsunomiya T et al : Huge focal nodular hyperplasia difficult to distinguish from well-differentiated hepatocellular carcinoma. Hepatol Res 42 : 727-731, 2012
  pubmed

P.100 掲載の参考文献

• 26) Nahm CB, Ng K, Lockie P et al : Focal nodular hyperplasia--a review of myths and truths. J Gastrointest Surg 15 : 2275-2283, 2011
  pubmed

P.101 掲載の参考文献

• 1) 市田隆文, 玄田拓哉 : 治療の最新情報HBVに対する最新の肝移植事情 肝移植後のHBV再感染とde novo肝炎に対する対応. 医学のあゆみ 242 : 455-459, 2012

P.102 掲載の参考文献

• 2) Ballarin R, Cucchetti A, Spaggiari M et al : Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors : a European multicentric case-control study. Transplantation 91 : 1265-272, 2011
  pubmed

• 3) Burr AT, Li Y, Tseng JF et al : Survival after liver transplantation using hepatitis C virus-positive donor allografts : case-controlled analysis of the UNOS database. World J Surg 35 : 1590-1595, 2011
  pubmed

• 4) Lai JC, Verna EC, Brown RS Jr et al : Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology 54 : 418-24, 2011
  pubmed

• 5) Monbaliu D, Pirenne J, Talbot D : Liver transplantation using Donation after Cardiac Death donors. J Hepatol 56 : 474-485, 2012
  pubmed

P.103 掲載の参考文献

• 6) Emre S, Umman V : Split liver transplantation : an overview. Transplant Proc 43 : 884-887, 2011
  pubmed

• 7) Ueda Y, Marusawa H, Kaido T et al : Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation. Hepatol Res 43 : 67-71, 2013
  pubmed

• 8) Cai CJ, Lu MQ, Chen YH et al : Clinical study on prevention of HBV re-infection by entecavir after liver transplantation. Clin Transplant 26 : 208-215, 2011
  pubmed

• 9) Fung J, Cheung C, Chan SC et al : Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology 141 : 1212-1219, 2011
  pubmed

• 10) Ishigami M, Kamei H, Nakamura T et al : Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts. J Gastroenterol 46 : 367-377, 2011
  pubmed

P.104 掲載の参考文献

• 11) Werner CR, Egetemeyr DP, Lauer UM et al : Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus : A 12-week pilot study providing safety and efficacy data. Liver Transpl 18 : 1464-1470, 2012
  pubmed

• 12) Al Nahdi N, Ford JA, Greanya ED et al : First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. Ann Hepatol 12 : 156-160, 2013

• 13) Cisneros E, Banos I, Citores MJ et al : Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860. Transplantation 94 : 275-280, 2012

• 14) Graziadei IW, Zoller HM, Schloegl A et al : Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation. Liver Transpl 18 : 671-679, 2012
  pubmed

• 15) Ghabril M, Dickson RC, Krishna M et al : Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence. Liver Transpl 17 : 685-694, 2011
  pubmed

P.105 掲載の参考文献

• 16) Duvoux C, Roudot-Thoraval F, Decaens T et al : Liver transplantation for hepatocellular carcinoma : a model including α-fetoprotein improves the performance of Milan criteria. Gastroentrology 143 : 986-994, 2012

• 17) Kaido T, Mori A, Ogura Y et al : Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection. Surgery 151 : 55-60, 2012
  pubmed

• 18) Majno P, Lencioni R, Mornex F et al : Is the treatment of hepatocellular carcinoma on the waiting list necessary? Liver Transpl 17 : S98-108, 2011
  pubmed

• 19) Lin Y, Chapman WC : Towards more effective liver allocation criteria for hepatocellular carcinoma : tumor response to locoregional therapy. Ann Surg Oncol 18 : 2416-2418, 2011
  pubmed

P.106 掲載の参考文献

• 20) Liang W, Wang D, Ling X et al : Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma : a meta-analysis. Liver Transpl 18 : 62-69, 2012

• 21) Gomez-Martin C, Bustamante J, Castroagudin JF et al : Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation. Liver Transpl 18 : 45-52, 2012
  pubmed

• 22) Staufer K, Fischer L, Seegers B et al : High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Transpl Int 25 : 1158-1164, 2012
  pubmed

• 23) 日本肝移植研究会 : 肝移植症例登録報告. 移植 47 : 416-432, 2012
  Medical*Online

• 24) Silveira MG, Talwalkar JA, Lindor KD et al : Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant 10 : 720-726, 2010
  pubmed

• 25) Kaneko J, Sugawara Y, Tamura S et al : Long-term outcome of living donor liver transplantation for primary biliary cirrhosis. Transpl Int 25 : 7-12, 2012
  pubmed

• 26) Choi HJ, You YK, Na GH et al : Single-port laparoscopy-assisted donor right hepatectomy in living donor liver transplantation : sensible approach or unnecessary hindrance? Transplant Proc 44 : 347-352, 2012
  pubmed

• 27) Eguchi S, Takatsuki M, Soyama A et al : Elective living donor liver transplantation by hybrid hand-assisted laparoscopic surgery and short upper midline laparotomy. Surgery 150 : 1002-1005, 2011
  pubmed

P.107 掲載の参考文献

• 28) Pedano N, Rotellar F, Alvarez-Cienfuegos J et al : Efficacy of laparoscopic approach in the management of early liver transplant complications. Transplant Proc 44 : 1560-1561, 2012
  pubmed

• 29) Cascales Campos P, Ramirez Romero P, Gonzalez R et al : Laparoscopic treatment of biliary peritonitis after removal of T-tube in liver transplant patients. Transplant Proc 44 : 1550-1553, 2012
  pubmed

• 30) Lai Q, Pinheiro RS, Levi Sandri GB et al : Laparoscopy in Liver Transplantation : The Future has Arrived. HPB Surg, 2012 (doi : 10.1155/2012/148387)

P.108 掲載の参考文献

• 1) 和久井紀貴, 高山竜司, 金川武徳 他 : 門脈圧亢進症の血行動態診断におけるParametric Imagingの有用性について. 日本門脈圧亢進症学会雑誌 18 (1) : 14-18, 2012

• 2) Shi KQ, Fan YC, Pan XF et al : Transient elastgraphy : a meta-analysis of diagnostic accuracy inevaluation of portal hypertension in chronic liver disease. Liver Int 33 (1) : 62-71, 2013 (doi : 10.1111/liv.12003. Epub 2012 Sep 14)

P.109 掲載の参考文献

• 3) Colecchia A, Montrone L, Scaioli E et al : Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143 : 646-654, 2012
  pubmed

• 4) Takuma Y, Nouso K, Morimoto Y et al : Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology 144 : 92-101, 2012
  pubmed

• 5) Sato T, Yamazaki K : Endoscopic color Doppler ultrasonography for esophagogastric varices. Diagn Ther Endosc, 2012 (doi : 10.1155/2012/859213. Epub 2012 Nov 19)

• 6) Azam Z, Hamid S, Jafri W et al : Short course adjuvant terlipressin in acute variceal bleeding : A randomized double blind dummy controlled trial. J hepatol 56 : 819-824, 2012

• 7) Funakoshi N, Duny Y, Valats JC et al : Meta-analysis ; beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol 11 (3) : 369-383, 2012
  pubmed

• 8) Hung HH, Chang CJ, Hou MC et al : Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding : A randomized controlled trial. J Hepatol 56 : 1025-1032, 2012

P.110 掲載の参考文献

• 9) Hidaka H, Nakazawa T, Wang G et al : Long-term administration PPI reduces treatment failures after esophageal variceal band ligation : a randomized, controlled trial. J Gastoenteorol 47 : 118-126, 2012

• 10) Iwase H, Shimada M, Tsuzuki T et al : Long-term results of endoscopic obliteration with cyanoacrylate glue for gastric fundal variceal bleeding : a 17-year experience. 日本門脈圧亢進症学会雑誌 17 (4) : 137-144, 2011

• 11) Hamza I, Mahmond M, Labib S : The initial experience of safety and efficacy of argon plasma coagulation (APC) in the primary prevention of variceal bleeding. Arab J Gastroenterol 13 : 125-129, 2012

• 12) Gonzalez A, Augustin S, Dot J et al : Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic nonresponders to pharmacological therapy. Dis Liver Dis 44 : 55-60, 2012
  pubmed

• 13) Thiele M, Krag A, Rohde U et al : Meta-analysis : banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther 35 : 1155-1165, 2012
  pubmed

P.111 掲載の参考文献

• 14) Gaba RC, Omene BO, Podczerwinski ES et al : TIPS for treatment of variceal hemorrhage : clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol 23 : 227-235, 2012

• 15) Clements W, Cavanagh K, Ali F et al : Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration : A pilot study. J Med Imaging Radiat Oncol 56 : 599-605, 2012
  pubmed

• 16) Sonomura T, Ono W, Sato M et al : Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices. World J Gastroenterol 18 (12) : 1373-1378, 2012
  pubmed

• 17) Zheng X, Liu Q, Tao Y : Laparoscopic spelenectomy and esophagogastric devascularization is a safe, effective, minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding. Surg Innov 20 : 32-39, 2013

P.112 掲載の参考文献

• 18) Hayashi H, Takamura H, Yamaguchi Y et al : Recent role of Hassab's operation for cirrhotic patients : Combination with endoscopic procedure for varices. Asian J Surg 35 : 57-61, 2012

• 19) Orloff MJ, Vaida F, Haynes KS et al : Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 16 : 2094-2111, 2012
  pubmed

• 20) Zhou J, Wu Z, Pankal P et al : Long-term postoperative outcomes of hypersplenism : laparoscopic versus open splenectomy secondary to liver cirrhosis. Surg Endosc 26 : 3391-3400, 2012

• 21) He XH, Gu JJ, Li WT et al : Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism. World J Gastroenterol 18 (24) : 3138-3144, 2012
  pubmed

P.113 掲載の参考文献

• 22) 田尻和人, 河合健吾, 時光善温 他 : 脾摘術を施行しインターフェロンを導入したC型肝硬変7症例の検討. 日本門脈圧亢進症学会雑誌 18 (1) : 40-44, 2012

P.114 掲載の参考文献

• 1) 厚生労働省 : 印刷業等の洗浄作業における有機塩素系洗浄剤のばく露低減化のための予防的取組みについて. 平成24年7月23日付基安発0723 第1号

• 2) Ogawa H, Itoh S, Nagasaka T et al : CT findings of intraductal papillary neoplasm of the bile duct : assessment with multiphase contrast-enhanced examination using multi-detector CT. Clin Radiol 67 : 224-231, 2012
  pubmed

P.115 掲載の参考文献

• 3) Ohtsubo I, Ajiki T, Hori Y et al : Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas. Hepatol Res 42 : 574-582, 2012
  pubmed

• 4) Feng YJ, Zhang BY, Yao RY et al : Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells. Hepatobiliary Pancreat Dis Int 11 : 418-423, 2012
  pubmed

• 5) Tretiakova M, Antic T, Westerhoff M et al : Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions. Am J Surg Pathol 36 : 101-108, 2012
  pubmed

P.116 掲載の参考文献

• 6) Fukami Y, Ebata T, Yokoyama Y et al : Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci 19 : 179-186, 2012

• 7) Ruys AT, Kate FJ, Busch OR et al : Metastatic lymph nodes in hilar cholangiocarcinoma : does size matter? HPB (Oxford) 13 : 881-886, 2011
  pubmed

• 8) Matsuo K, Rocha FG, Ito K et al : The Blumgart preoperative staging system for hilar cholangiocarcinoma : analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215 : 343-355, 2012
  pubmed

P.117 掲載の参考文献

• 9) Qiao QL, Zhang TP, Guo JC et al : Prognostic factors after pancreatoduodenectomy for distal bile duct cancer. Am Surg 77 : 1445-1448, 2012

• 10) Lee SE, Jang JY, Lee YJ et al : Choledochal cyst and associated malignant tumors in adults : a multicenter survey in South Korea. Arch Surg 146 : 1178-1184, 2011
  pubmed

• 11) Endo I, Matsuyama R, Taniguchi K et al : Right hepatectomy with resection of caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 19 : 2162-24, 2012

• 12) Neuhaus P, Thelen A, Jonas S et al : Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 19 : 1602-1608, 2012

• 13) Natsume S, Ebata T, Yokoyama Y et al : Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma : an appraisal and comparison with left hepatectomy. Ann Surg 255 : 754-762, 2012
  pubmed

P.118 掲載の参考文献

• 14) Young AL, Igami T, Senda Y et al : Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) 13 : 483-493, 2011

• 15) Nuzzo G, Giuliante F, Ardito F et al : Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma : results of an Italian multicenter analysis of 440 patients. Arch Surg 147 : 26-34, 2012
  pubmed

• 16) Wahab MA, Sultan AM, Salah T et al : Caudate lobe resection with major hepatectomy for central cholangiocarcinoma : is it of value? Hepatogastroenterology 59 : 321-324, 2012
  pubmed

• 17) Ribero D, Amisano M, Lo Tesoriere R et al : Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg 254 : 776-781, 2011
  pubmed

P.119 掲載の参考文献

• 18) Noji T, Miyamoto M, Kubota KC et al : Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 10 : 106, 2012
  pubmed

• 19) Darwish Murad S, Kim WR, Harnois DM et al : Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 143 : 88-98, 2012
  pubmed

• 20) Chatelain D, Farges O, Fuks D et al : Assessment of pathology reports on hilar cholangiocarcinoma : the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. J Hepatol 56 : 1121-1128, 2012

P.120 掲載の参考文献

• 21) Lai EC, Yang GP, Tang CN : Robot-assisted laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy--a comparative study. Int J Surg 10 : 475-479, 2012
  pubmed

• 22) Croitoru A, Gramaticu I, Dinu I et al : Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma-a retrospective study. J Gastrointestin Liver Dis 21 : 277-284, 2012
  pubmed

• 23) Katayose Y, Ohtsuka H, Kitamura Y et al : An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. Hepatogastroenterology 59 : 691-695, 2012

• 24) Yi JH, Thongprasert S, Lee J et al : A phase II study of sunitinib as a secondline treatment in advanced biliary tract carcinoma : a multicentre, multinational study. Eur J Cancer 48 : 196-201, 2012

P.121 掲載の参考文献

• 25) Isayama H, Tsujino T, Nakai Y et al : Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World J Gastroenterol 18 : 2364-2370, 2012
  pubmed

• 26) Cheon YK, Lee TY, Lee SM et al : Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 14 : 185-193, 201
  pubmed

• 27) Zhao XQ, Dong JH, Zhang WZ et al : Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin. Diagn Pathol 6 : 98, 2011
  pubmed

P.122 掲載の参考文献

• 28) Salmi S, Ezzedine S, Vitton V et al : Can papillary carcinomas be treated by endoscopic ampullectomy? Surg Endosc 26 : 920-925, 2012
  pubmed

• 29) Chen G, Wang H, Fan Y et al : Pancreassparing duodenectomy with regional lymphadenectomy for pTis and pT1 ampullary carcinoma. Surgery 151 : 510-517, 2012

• 30) Palta M, Patel P, Broadwater G et al : Carcinoma of the ampulla of Vater : patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol 19 : 1535-1540, 2012

P.123 掲載の参考文献

• 1) Sobin LH, Gospodarowicz MK, Wittekind C eds : "TNM classification of malignant tumours, Seventh Edition", Wiley-Blackwell, 2010

• 2) Witjes CD, van den Akker SA, Visser O et al : Gallbladder cancer in the Netherlands : incidence, treatment and survival patterns since 1989. Dig Surg 29 (2) : 92-98, 2012
  pubmed

P.124 掲載の参考文献

• 3) 石原慎, 宮川秀一, 堀口明彦 他 : 疫学-胆道癌全国登録データよりみた胆嚢癌の動向. 肝胆膵 64 (4) : 461-466, 2012

• 4) Kim HJ, Park JH, Park DI et al : Clinical usefulness of endoscopic ultrasonography in the differential diagnosis of gallbladder wall thickening. Dig Dis Sci 57 (2) : 508-515, 2012
  pubmed

• 5) Hijioka S, Hara K, Mizuno N et al : Diagnostic yield of endoscopic retrograde cholangiography and of EUS-guided fine needle aspiration sampling in gallbladder carcinomas. J Hepatobiliary Pancreat Sci 19 (6) : 650-655, 2012

• 6) Xiong L, Yang Z, Yang L et al : Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. J Surg Oncol 105 (1) : 97-103, 2012
  pubmed

• 7) Kai K, Ide T, Masuda M et al : Clinicopathologic features of advanced gallbladder cancer associated with adenomyomatosis. Virchows Arch 459 (6) : 573-580, 2011
  pubmed

P.125 掲載の参考文献

• 8) Okada K, Kijima H, Imaizumi T et al : Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma. Oncol Rep 28 (5) : 1531-1536, 2012
  pubmed

• 9) Kishi Y, Shimada K, Hata S et al : Definition of T3/4 and regional lymph nodes in gallbladder cancer : which is more valid, the UICC or the Japanese staging system? Ann Surg Oncol 19 (11) : 3567-3573, 2012
  pubmed

• 10) 石原慎, 宮川秀一, 堀口明彦 他 : 開腹胆嚢摘出術および胆嚢癌症例におけるIncidental Gallbladder Cancerの頻度. 胆と膵 32 (5) : 379-383, 2011
  Medical*Online

• 11) 胆道癌診療ガイドライン作成出版委員会 編 : "エビデンスに基づいた胆道癌診療ガイドライン", 医学図書出版, 2007

P.126 掲載の参考文献

• 12) Mazer LM, Losada HF, Chaudhry RM et al : Tumor characteristics and survival analysis of incidental versus suspected gallbladder carcinoma. J Gastrointest Surg 16 (7) : 1311-1317, 2012
  pubmed

• 13) Clemente G, Nuzzo G, De Rose AM et al : Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis : a worrisome picture. J Gastrointest Surg 16 (8) : 1462-1468, 2012
  pubmed

• 14) Lendoire JC, Gil L, Duek F et al : Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) 14 (8) : 548-553, 2012
  pubmed

• 15) Hari DM, Howard JH, Leung AM et al : A 21-year analysis of stage I gallbladder carcinoma : is cholecystectomy alone adequate? HPB (Oxford) 15 (1) : 40-48, 2013

P.127 掲載の参考文献

• 16) Lim CS, Jang JY, Lee SE et al : Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer. J Gastrointest Surg 16 (5) : 1012-1018, 2012
  pubmed

• 17) 伊神剛, 江畑智希, 横山幸治 他 : 外科治療B-inf症例の手術適応はあるか? 肝胆膵 64 (4) : 569-574, 2012

• 18) Shirai Y, Sakata J, Wakai T et al : "Extended" radical cholecystectomy for gallbladder cancer : long-term outcomes, indications and limitations. World J Gastroenterol 18 (34) : 4736-4743, 2012
  pubmed

P.128 掲載の参考文献

• 19) Choi SB, Han HJ, Kim CY et al : Fourteen year surgical experience of gallbladder cancer : validity of curative resection affecting survival. Hepatogastroenterology 59 (113) : 36-41, 2012
  pubmed

• 20) Cziupka K, Partecke LI, Mirow L et al : Outcomes and prognostic factors in gallbladder cancer : a single-centre experience. Langenbecks Arch Surg 397 (6) : 899-907, 2012
  pubmed

• 21) Konishi M : Adjuvant chemotherapy for resectable biliary tract cancer : current status and future direction. J Hepatobiliary Pancreat Sci 19 (4) : 301-305, 2012

• 22) Horgan AM, Amir E, Walter T et al : Adjuvant therapy in the treatment of biliary tract cancer : a systematic review and meta-analysis. J Clin Oncol 30 (16) : 1934-1940, 2012
  pubmed

P.129 掲載の参考文献

• 1) Zubaidi AM : Single-port laparascopic cholecystectomy : scarless cholecystectomy. Minim Invasive Surg, 2012 (doi : 10.1155/2012/204380)

• 2) Ceci F, Di Grazia C, Cipriani B et al : Cholecystectomy by single incision laparoscopic surgery (SILS) : early experience and technique standardization. G Chir 33 (8-9) : 280-284, 2012
  pubmed

• 3) Chang SK, Wang YL, Shen L et al : Interim report : A randomized controlled trial comparing postoperative pain in single-incision laparoscopic cholecystectomy and conventional laparoscopic cholecystectomy. Asian J Endosc Surg 6 : 14-20, 2013
  pubmed

• 4) Videhult P, Sandblom G, Rudberg C et al : Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy. HPB (Oxford) 13 (8) : 519-527, 2011
  pubmed

P.130 掲載の参考文献

• 5) Yasui T, Takahata S, Kono H et al : Is cholecystectomy necessary after endoscopic treatment of bile duct stones in patients older than 80 years of age? J Gastroenterol 47 (1) : 65-70, 2012

• 6) Tsuyuguchi T, Sugiyama H, Sakai Y et al : Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines. J Hepatobiliary Pancreat Sci 19 (5) : 557-565, 2012

• 7) Asai K, Watanabe M, Kusachi S et al : Changes in the therapeutic strategy for acute cholecystitis after the Tokyo guidelines were published. J Hepatobiliary Pancreat Sci, 2012 (doi : 10.1007/s00534-012-0536-4)

• 8) Asai K, Watanabe M, Kusachi S et al : Bacteriological analysis of bile in acute cholecystitis according to the Tokyo guidelines. J Hepatobiliary Pancreat Sci 19 (4) : 476-486, 2012

• 9) Nikfarjam M, Niumsawatt V, Sethu A et al : Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis. HPB (Oxford) 13 (8) : 551-558, 2011
  pubmed

P.131 掲載の参考文献

• 10) Kiriyama S, Takada T, Strasberg SM et al : New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci 19 (5) : 548-556, 2012

• 11) Yokoe M, Takada T, Strasberg SM et al : New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci 19 (5) : 578-585, 2012

P.132 掲載の参考文献

• 12) Kogure H, Tsujino T, Yamamoto K et al : Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage. J Gastroenterol 46 (12) : 1411-1417, 2011
  pubmed

• 13) Jang JW, Lee SS, Song TJ et al : Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology 142 (4) : 805-811, 2012
  pubmed

• 14) 松元淳, 古賀哲也, 今給黎和幸 他 : 急性胆嚢炎に対する経皮的肝胆嚢吸引穿刺法 (PTGBA) の有用性. 胆道 26 (2) : 189-195, 2012

P.133 掲載の参考文献

• 15) Rodriguez-Sanjuan JC, Arruabarrena A, Sanchez-Moreno L : Acute cholecystitis in high surgical risk patients : percutaneous cholecystostomy or emergency cholecystectomy? Am J Surg 204 (1) : 54-9, 2012
  pubmed

• 16) McKay A, Abulfaraj M, Lipschitz J : Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients. Surg Endosc 26 (5) : 1343-1351, 2012

• 17) Kortram K, van Ramshorst B, Bollen TL et al : Acute cholecystitis in high risk surgical patients : percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial) : study protocol for a randomized controlled trial. Trials 13 : 1-7, 2012

• 18) Cherng N, Witkowski ET, Sneider EB et al : Use of cholecystostomy tubes in the management of patients with primary diagnosis of acute cholecystitis. J Am Coll Surg 214 (2) : 196-201, 2012
  pubmed

• 19) Kim IG, Kim JS, Jeon JY et al : Percutaneous transhepatic gallbladder drainage changes emergency laparoscopic cholecystectomy to an elective operation in patients with acute cholecystitis. J Laparoendosc Adv Surg Tech A 21 (10) : 941-946, 2011

• 20) Johner A, Raymakers A, Wiseman SM : Cost utility of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Surg Endosc 27 (1) : 256-262, 2013
  pubmed

• 21) Navez B, Ungureanu F, Michiels M et al : Surgical management of acute cholecystitis : results of a 2-year prospective multicenter survey in Belgium. Surg Endosc 26 (9) : 2436-2445, 201
  pubmed

P.134 掲載の参考文献

• 1) 武田和憲, 片岡慶正, 木原康之, 他 : 急性膵炎重症度判定基準の改定とガイドライン 2010. 日本腹部救急医学会雑誌 31 (3) : 523-528, 2011

• 2) 急性膵炎診療ガイドライン2010改訂出版委員会 編 : "急性膵炎診療ガイドライン2010 [第3版]", 金原出版, 2009

• 3) Banks PA, Bollen TL, Dervenis C et al : Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012 : revision of the Atlanta classification and definitions by international consensus. Gut 62 (1) : 102-111, 2013

P.135 掲載の参考文献

• 4) Satoh K, Shimosegawa T, Masamune A et al : Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of acute pancreatitis in Japan. Pancreas 40 (4) : 503-507, 2011
  pubmed

• 5) Zhou W, Li Y, Zhang Q et al : Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis : a retrospective analysis of 7, 168 cases. Pancreatology 11 (4) : 399-405, 2011

• 6) Park KT, Kang DH, Choi CW et al : Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 40 (8) : 1215-1219, 2011
  pubmed

• 7) Katsinelos P, Fasoulas K, Paroutoglou G et al : Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis : a randomized, double-blind, placebo-controlled trial. Endoscopy 44 (1) : 53-59, 2012
  pubmed

• 8) Xu LH, Qian JB, Gu LG et al : Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla. J Gastroenterol Hepatol 26 (7) : 1139-1144, 2011
  pubmed

• 9) Wu BU, Hwang JQ, Gardner TH et al : Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 9 (8) : 710-717, 2011
  pubmed

P.136 掲載の参考文献

• 10) Du XJ, Hu WM, Xia Q et al : Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas 40 (8) : 1220-1225, 2011
  pubmed

• 11) Trikudanathan G, Navaneethan U, Vege SS : Current controversies in fluid resuscitation in acute pancreatitis : a systematic review. Pancreas 41 (6) : 827-834, 2012
  pubmed

• 12) Yi F, Ge L, Zhao J, et al : Meta-analysis : total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med 51 (6) : 523-530, 2012
  pubmed

• 13) Singh N, Sharma B, Sharma M et al : Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis : a noninferiority randomized controlled trial. Pancreas 41 (1) : 153-159, 2012

• 14) Bakker OJ, van Santvoort HC, van Brunschot S et al ; Dutch Pancreatitis Study Group : Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis : a randomized trial. JAMA 307 (10) : 1053-1061, 2012

• 15) van Santvoort HC, Bakker OJ, Bollen TL et al ; Dutch Pancreatitis Study Group : A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology 141 (4) : 1254-1263, 2011

P.137 掲載の参考文献

• 16) Haghshenasskashani A, Laurence JM, Kwan V, et al : Endoscopic necrosectomy of pancreatic necrosis : a systematic review. Surg Endosc 25 (12) : 3724-3730, 2011
  pubmed

• 17) Lankisch PG, Weber-Dany B, Maisonneuve P et al : Pancreatic pseudocysts : prognostic factors for their development and their spontaneous resolution in the setting of acute pancreatitis. Pancreatology 12 (2) : 85-90, 2012
  pubmed

• 18) van Baal MC, Besselink MG, Bakker OJ et al ; Dutch Pancreatitis Study Group : Timing of cholecystectomy after mild biliary pancreatitis : a systematic review. Ann Surg 255 (5) : 860-866, 2012

• 19) Bakker OJ, van Santvoort HC, Hagenaars JC, et al ; Dutch Pancreatitis Study Group : Timing of cholecystectomy after mild biliary pancreatitis. Br J Surg 98 (10) : 1446-1454, 2011

• 20) 厚生労働省難治性膵疾患に関する調査研究班, 日本膵臓学会, 日本消化器病学会 : 慢性膵炎臨床診断基準 2009. 膵臓 24 : 645-646, 2009
  Medical*Online

• 21) 日本消化器病学会 編 : "慢性膵炎診療ガイドライン", 南江堂, 2009

• 22) Thorat V, Reddy N, Bhatia S et al : Randomised clinical trial : the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 36 (5) : 426-436, 2012
  pubmed

• 23) Siriwardena AK, Mason JM, Sheen AJ et al : Antioxidant therapy does not reduce pain in patients with chronic pancreatitis : the ANTICIPATE study. Gastroenterology 143 (3) : 655-663, 2012

• 24) Mirtallo JM, Forbes A, McClave SA et al ; International Consensus Guideline Committee Pancreatitis Task Force : International consensus guidelines for nutrition therapy in pancreatitis. JPEN J Parenter Enteral Nutr 36 (3) : 284-291, 2012
  pubmed

• 25) Olesen SS, Bouwense SA, Wilder-Smith OH et al : Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 141 (2) : 536-543, 2011

P.138 掲載の参考文献

• 26) Keck T, Adam U, Makowiec F et al : Short- and long-term results of duodenum preservation versus resection for the management of chronic pancreatitis : a prospective, randomized study. Surgery 152 (3 Suppl 1) : S95-S102, 2012

• 27) Bramis K, Gordon-Weeks AN, Friend PJ et al : Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg 99 (6) : 761-766, 2012
  pubmed

• 28) 乾和郎, 五十嵐良典, 入澤篤志, 他 : 慢性膵炎の合併症に対する内視鏡治療ガイドライン. "膵石症の内視鏡治療ガイドライン". 膵臓 25 : 553-577, 2010
  Medical*Online

• 29) Hong J, Wang J, Keleman AM et al : Endoscopic versus surgical treatment of downstream pancreatic duct stones in chronic pancreatitis. Am Surg 77 (11) : 1531-1538, 2011

• 30) Cahen DL, Gouma DJ, Laramee P et al : Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 141 (5) : 1690-1695, 2011
  pubmed

P.139 掲載の参考文献

• 1) Nimura Y, Nagino M, Takao S et al : Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas : long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19 : 230-241, 2012

P.140 掲載の参考文献

• 2) National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. Version 2. 2012
  pubmed

• 3) 蒲田敏文, 龍泰治, 南哲弥 他 : 膵癌におけるDynamic CT撮像方法と脈管浸潤. 胆と膵 32 : 585-592, 2011
  Medical*Online

• 4) 北川裕久, 蒲田敏文, 大坪公士郎 : 画像と病理の対比から学ぶ膵癌診療アトラス. 学研メディカル秀潤社, 2012

• 5) 北川裕久, 田島秀浩, 中川原寿俊 他 : Borderline Resectable膵頭部癌の診断と治療成績. 胆と膵 32 : 609-614, 2011
  Medical*Online

P.141 掲載の参考文献

• 6) 牧野勇, 北川裕久, 太田哲生 他 : 膵頭十二指腸切除に必要な局所解剖. 外科 74 : 1397-1404, 2012

• 7) Kawabata Y, Tanaka T, Nishi T et al : Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 38 : 574-579, 2012
  pubmed

• 8) Motoi F, Egawa S, Rikiyama T et al : Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br J Surg 99 : 524-531, 2012
  pubmed

• 9) Zhou Y, Zhou Q, Li Z et al : The Impact of internal or external transanastomotic pancreatic duct stents following pancreaticojejunostomy. Which one is better? A meta-analysis. J Gastrointest Surg 16 : 2322-2335, 2012

• 10) Xiong JJ, Altaf K, Mukherjee R et al : Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy. Br J Surg 99 : 1050-1061, 2012
  pubmed

P.142 掲載の参考文献

• 11) Mitchem JB, Hamilton N, Gao F et al : Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg 214 : 46-52, 2012
  pubmed

• 12) Strasberg SM, Fields R : Left-sided pancreatic cancer : distal pancreatectomy and its variants : radical antegrade modular pancreatosplenectomy and distal pancreatectomy with celiac axis resection. Cancer J 18 : 562-570, 2012
  pubmed

• 13) Diener MK, Seiler CM, Rossion I et al : Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT) : a randomised, controlled multicentre trial. Lancet 377 : 1514-1522, 2011
  pubmed

• 14) Frozanpor F, Lundell L, Segersvard R et al : The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy : results of a prospective controlled clinical trial. Ann Surg 255 : 1032-1036, 2012
  pubmed

• 15) Montorsi M, Zerbi A, Bassi C et al ; Italian Tachosil Study Group : Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy : a multicenter, randomized, controlled trial. Ann Surg 256 : 853-859 ; discussion 859-860, 2012

• 16) Makino I, Kitagawa H, Ohta T et al : The management of a remnant pancreatic stump for preventing the development of postoperative pancreatic fistulas after distal pancreatectomy : current evidence and our strategy. Surg Today, 2012 (doi : 10.1007/s00595-012-0370-y)

• 17) Assifi MM, Lu X, Eibl G et al : Neoadjuvant therapy in pancreatic adenocarcinoma : A meta-analysis of phase II trials. Surgery 150 : 466-473, 2011
  pubmed

• 18) Andriulli A, Festa V, Botteri E et al : Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer : a meta-analysis of prospective studies. Ann Surg Oncol 19 : 1644-1662, 2012

P.143 掲載の参考文献

• 19) 大東弘明, 高橋秀典, 石川治 : 膵癌に対する術前化学療法. 日消誌 108 : 1646-1653, 2011

• 20) Satoi S, Toyokawa H, Yanagimoto H et al : Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer. J Gastrointest Surg 16 : 784-792, 2012
  pubmed

• 21) Chua TC, Saxena A : Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer : a review of current results. Surg Oncol 20 : e161-168, 2011
  pubmed

• 22) Estrella JS, Rashid A, Fleming JB et al : Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118 : 268-277, 2012
  pubmed

• 23) Wang J, Estrella JS, Peng L et al : Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118 : 3801-3811, 2012
  pubmed

• 24) Chatterjee D, Rashid A, Wang H et al : Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol 36 : 552-559, 2012
  pubmed

• 25) Chatterjee D, Katz MH, Rashid A et al : Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 36 : 409-417, 2012
  pubmed

• 26) Laurence JM, Tran PD, Morarji K et al : A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg 15 : 2059-2069, 2011
  pubmed

• 27) Heinrich S, Pestalozzi B, Lesurtel M et al : Adjuvant gemcitabine versus NEO-adjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer : a randomized multicenter phase III study (NEOPAC study). BMC Cancer 11 : 346, 2011
  pubmed

P.144 掲載の参考文献

• 28) Conroy T, Desseigne F, Ychou M et al : FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364 : 1817-1825, 2011
  pubmed

• 29) Koido S, Homma S, Takahara A et al : Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol, 2011 (doi : 10.1155/2011/267539)

P.145 掲載の参考文献

• 30) Miyazawa M, Yamaue H : The development of a novel cancer vaccine using Peptide vaccine for patients with advanced pancreatic cancer. Gan To Kagaku Ryoho 38 : 1903-1905, 2011
  pubmed

P.146 掲載の参考文献

• 1) Tanaka M, Fernandez-del Castillo C, Adsay V et al : International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12 (3) : 183-197, 2012
  pubmed

• 2) Tanaka M, Chari S, Adsay V, et al : International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6 (1-2) : 17-32, 2006

P.148 掲載の参考文献

• 3) Bosman FT, Carneiro F, Hruban RH et al : WHO Classification of Tumours of the Digestive System. IARC : Lyon, France, 2010

• 4) Salvia R, Malleo G, Marchegiani G et al : Pancreatic resections for cystic neoplasms : from the surgeon's presumption to the pathologist's reality. Surgery 152 (3 Suppl 1) : S135-142, 2012

• 5) Kim JH, Hong SS, Kim YJ et al : Intraductal papillary mucinous neoplasm of the pancreas : differentiate from chronic pancreatits by MR imaging. Eur J Radiol 81 (4) : 671-676, 2012
  pubmed

P.149 掲載の参考文献

• 6) Hirono S, Tani M, Kawai M et al : The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 255 (3) : 517-522, 2012
  pubmed

• 7) Pedrazzoli S, Sperti C, Pasquali C et al : Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 254 (6) : 971-976, 2011
  pubmed

• 8) Murayama S, Kimura W, Hirai I et al : Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging. Pancreas 40 (6) : 876-882, 2011
  pubmed

P.150 掲載の参考文献

• 9) Genevay M, Mino-Kenudson M, Yaeger K et al : Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 254 (6) : 977-983, 2011
  pubmed

• 10) Kang MJ, Jang JY, Kim SJ et al : Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 9 (1) : 87-93, 2011
  pubmed

• 11) Cauley CE, Waters JA, Dumas RP et al : Outcomes of primary surveillance for intraductal papillary mucinous neoplasm. J Gastrointest Surg 16 (2) : 258-267, 2012
  pubmed

P.151 掲載の参考文献

• 12) Moriya T, Hashimoto Y, Traverso LW : The duration of symptoms predicts the presence of malignancy in 210 resected cases of pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 15 (5) : 762-771, 2011
  pubmed

• 13) Traverso LW, Moriya T, Hashimoto Y : Intraductal papillary mucinous neoplasms of the pancreas : making a disposition using the natural history. Curr Gastroenterol Rep 14 (2) : 106-111, 2012
  pubmed

• 14) Fritz S, Klauss M, Bergmann F et al : Small (Sendai negative) branch-duct IPMNs : not harmless. Ann Surg 256 (2) : 313-320, 2012
  pubmed

• 15) Ohtsuka T, Kono H, Tanabe R et al : Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas ; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 204 (1) : 44-48, 2012

P.152 掲載の参考文献

• 16) Miller JR, Meyer JE, Waters JA et al : Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford) 13 (11) : 759-766, 2011
  pubmed

• 17) Lafemina J, Katabi N, Klimstra D et al : Malignant progression in IPMN : A cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol 20 (2) : 440-447, 2013

• 18) 木村理, 高須直樹, 村山最二郎 : 膵管内乳頭粘液性腫瘍の国際診療ガイドラインと診療の現状. 日本内科学会雑誌 101 (1) : 79-92, 2011

• 19) Jang JY, Hwang DW, Kim MA et al : Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms. Ann Surg Oncol 18 (3) : 644-650, 2011

• 20) Takeshita A, Kimura W, Hirai I et al : Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma. Pancreas 41 (1) : 114-120, 2012
  pubmed

P.153 掲載の参考文献

• 21) Canto MI, Hruban RH, Fishman EK et al : Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142 (4) : 796-804, 2012
  pubmed

• 22) Matthaei H, Norris AL, Tsiatis AC et al : Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 255 (2) : 326-333, 2012
  pubmed

• 23) Furukawa T, Kuboki Y, Tanji E et al : Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1 : 161, 2011
  pubmed

• 24) Mohri D, Asaoka Y, Ijichi H et al : Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J Gastroenterol 47 (2) : 203-213, 2012
  pubmed

P.154 掲載の参考文献

• 25) Xiao HD, Yamaguchi H, Dias-Santagata D et al ; Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 224 (4) : 508-516, 2011
  pubmed

• 26) Kimura W, Moriya T, Hirai I et al : Multicenter study of serous cystic neoplasm of the Japan Pancreas Society. Pancreas 41 (3) : 380-387, 2012
  pubmed

• 27) Khashab MA, Shin EJ, Amateau S et al : Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol 106 (8) : 1521-1526, 2011
  pubmed

P.155 掲載の参考文献

• 28) Malleo G, Bassi C, Rossini R et al : Growth pattern of serous cystic neoplasms of the pancreas : observational study with long-term magnetic resonance surveillance and recommendations for treatment. Gut 61 (5) : 746-751, 2012
  pubmed

• 29) Yamaguchi H, Kuboki Y, Hatori T et al : Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 35 (12) : 1812-1817, 2011
  pubmed

P.156 掲載の参考文献

• 1) Yachida S, Vakiani E, White CM et al : Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 36 : 173-184, 2012
  pubmed

P.157 掲載の参考文献

• 2) Schimmack S, Lawrence B, Svejda B et al : The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms. Cancer 118 : 2763-2775, 2011
  pubmed

• 3) Kloppel G : Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 18 (Suppl 1) : S1-16, 2011

• 4) Atiq M, Bhutani MS, Bektas M et al : EUS-FNA for pancreatic neuroendocrine tumors : a tertiary cancer center experience. Dig Dis Sci 57 : 791-800, 2012
  pubmed

• 5) Hamilton NA, Liu TC, Cavatiao A et al : Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms. Surgery 152 : 107-113, 2012
  pubmed

P.158 掲載の参考文献

• 6) Haynes AB, Deshpande V, Ingkakul T et al : Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors : short-term and long-term patient outcomes. Arch Surg 146 : 534-538, 2011
  pubmed

• 7) Lee LC, Grant CS, Salomao DR et al : Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs) : role for nonoperative management. Surgery 152 : 965-974, 2012
  pubmed

• 8) Tsutsumi K, Ohtsuka T, Mori Y et al : Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. J Gastroenterol 47 : 678-685, 2012
  pubmed

P.159 掲載の参考文献

• 9) Kim MJ, Choi DW, Choi SH et al : Surgical strategies for non-functioning pancreatic neuroendocrine tumours. Br J Surg 99 : 1562-1568, 2012
  pubmed

• 10) Hackert T, Hinz U, Fritz S et al : Enucleation in pancreatic surgery : indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg 396 : 1197-1203, 2011
  pubmed

• 11) Haugvik SP, Marangos IP, Rosok BI et al : Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors. World J Surg 37 : 582-590, 2013
  pubmed

P.160 掲載の参考文献

• 12) Yao JC, Shah MH, Ito T, et al : Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364 : 514-523, 2011
  pubmed

• 13) Ito T, Okusaka T, Ikeda M et al : Everolimus for advanced pancreatic neuroendocrine tumours : a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial. Jpn J Clin Oncol 42 : 903-911, 2012
  pubmed

• 14) Brixi-Benmansour H, Jouve JL, Mitry E et al : Phase II study of first-line FOLFIRI for progressive metastatic well-differentiated pancreatic endocrine carcinoma. Dig Liver Dis 43 : 912-916, 2011
  pubmed

P.161 掲載の参考文献

• 15) Huang SC, Ng KF, Yeh TS et al : Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas. Ann Surg Oncol 19 (Suppl 3) : S438-446, 2012

• 16) Butte JM, Brennan MF, Gonen M et al : Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. J Gastrointest Surg 15 : 350-357, 2011

• 17) Cai H, Zhou M, Hu Y et al : Solid-pseudopapillary neoplasms of the pancreas : clinical and pathological features of 33 cases. Surg Today 43 : 148-154, 2013
  pubmed

P.162 掲載の参考文献

• 18) Ballarin R, Spaggiari M, Cautero N et al : Pancreatic metastases from renal cell carcinoma : the state of the art. World J Gastroenterol 17 : 4747-4756, 2011
  pubmed

P.163 掲載の参考文献

• 1) 日本外傷学会外傷研修コース開発委員会 編 : "外傷初期診療ガイドライン JATEC(TM) 改訂第4版", へるす出版, 2012

• 2) Laselle BT, Byyny RL, Haukoos JS et al : False-negative FAST examination : associations with injury characteristics and patient outcomes. Ann Emerg Med 60 : 326-334, 2012
  pubmed

• 3) van der Vlies CH, Olthof DC, Gaakeer M et al : Changing patterns in diagnostic strategies and the treatment of blunt injury to solid abdominal organs. Int J Emerg Med 4 : 47, 2011
  pubmed

P.164 掲載の参考文献

• 4) Wang YC, Hsieh CH, Fu CY et al : Hollow organ perforation in blunt abdominal trauma : the role of diagnostic peritoneal lavage. Am J Emerg Med 30 : 570-573, 2012
  pubmed

• 5) Mihalik JE, Smith RS, Toevs CC et al : The use of contrast-enhanced ultrasound for the evaluation of solid abdominal organ injury in patients with blunt abdominal trauma. J Trauma Acute Care Surg 73 : 1100-1105, 2012
  pubmed

• 6) Matsumoto H, Mashiko K, Sakamoto Y et al : A new look at criteria for damagecontrol surgery. J Nippon Med Sch 77 : 13-20, 2010

• 7) 久志本成樹 : ダメージコントロール. "手術動画とシェーマでわかる外傷外科手術スタンダート" (日本Acute Care Surgery学会 編), 羊土社, pp124-143, 2012

P.165 掲載の参考文献

• 8) Stassen NA, Bhullar I, Cheng JD et al : Nonoperative management of blunt hepatic injury : An Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 73 : S288-293, 2012
  pubmed

• 9) Letoublon C, Morra I, Chen Y et al : Hepatic arterial embolization in the management of blunt hepatic trauma : indications and complications. J Trauma 70 : 1032-1037, 2011
  pubmed

• 10) 久志本成樹, 宮内雅人, 増野智彦 他 : Damage control surgeryを要する重症肝損傷治療におけるIVRの重要性. 日外傷会誌 25 : 11-18, 2011

P.166 掲載の参考文献

• 11) 佐々木純, 鈴木涼平, 北村陽平 他 : 外傷性脾損傷に対する治療戦略. 日腹部救急医会誌 32 : 1163-1167, 2012

• 12) Stassen NA, Bhullar I, Cheng JD et al : Selective nonoperative management of blunt splenic injury : an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 73 : S294-300, 2012
  pubmed

• 13) Brault-Noble G, Charbit J, Chardon P et al : Age should be considered in the decision making of prophylactic splenic angioembolization in nonoperative management of blunt splenic trauma : a study of 208 consecutive civilian trauma patients. J Trauma Acute Care Surg 73 : 1213-1220, 2012
  pubmed

• 14) Bhullar IS, Frykberg ER, Siragusa D et el : Age does not affect outcomes of nonoperative management of blunt splenic trauma. J Am Coll Surg 214 : 958-964, 2012

• 15) Skattum J, Naess PA, Gaarder C : Nonoperative management and immune function after splenic injury. Br J Surg 99 (Suppl 1) : 59-65, 2012

• 16) Desir A, Ghaye B : CT of blunt diaphragmatic rupture. Radiographics 32 : 477-498, 2012
  pubmed

• 17) Bocchini G, Guida F, Sica G et al : Diaphragmatic injuries after blunt trauma : are they still a challenge? Reviewing CT findings and integrated imaging. Emerg Radiol 19 : 225-235, 2012

• 18) Malgras B, Douard R, Siauve N et al : Management of left pancreatic trauma. Am Surg 77 : 1-9, 2011
  pubmed

P.167 掲載の参考文献

• 19) Sharpe JP, Magnotti LJ, Weinberg JA et al : Impact of a defined management algorithm on outcome after traumatic pancreatic injury. J Trauma Acute Care Surg 72 : 100-105, 2012
  pubmed

• 20) Cigdem MK, Senturk S, Onen A et al : Nonoperative management of pancreatic injuries in pediatric patients. Surg Today 41 : 655-659, 2011
  pubmed

• 21) Ito Y, Kenmochi T, Irino T et al : Endoscopic management of pancreatic duct injury by endoscopic stent placement : a case report and literature review. World J Emerg Surg 7 : 21, 2012 (doi : 10.1186/1749-7922-7-21)

• 22) Antonacci N, Di Saverio S, Ciaroni V et al : Prognosis and treatment of pancreaticoduodenal traumatic injuries : which factors are predictors of outcome? J Hepaticobiliary Pancreat Sci 18 : 195-201, 2011

• 23) 村尾佳則, 横山恵一, 松島知秀 他 : 膵・十二指腸外傷. 救急医学 36 : 81-88, 2012

P.168 掲載の参考文献

• 24) 船曵知弘, 山崎元靖, 折田智彦 他 : 腸管腸間膜損傷の治療戦略. 日腹部救急医会誌 32 : 1187-1193, 2012

• 25) Walker ML, Akpele I, Spence SD et al : The role of repeat computed tomography scan in the evaluation of blunt bowel injury. Am Surg 78 : 979-985, 2012
  pubmed

• 26) Sharpe JP, Magnotti LJ, Weinberg JA et al : Adherence to a simplified management algorithm reduces morbidity and mortality after penetrating colon injuries : a 15-year experience. J Am Coll Surg 214 : 591-598, 2012
  pubmed

• 27) Sharpe JP, Magnotti LJ, Weinberg JA et al : Impact of location on outcome after penetrating colon injuries. J Trauma Acute Care Surg 73 : 1428-1432, 2012
  pubmed

P.170 掲載の参考文献

• 1) Garg P, Thakur JD, Garg M et al. Single-incision laparoscopic cholecystectomy vs. conventional laparoscopic cholecystectomy : a meta-analysis of randomized controlled trials. J Gastrointest Surg 16 (8) : 1618-1628, 2012
  pubmed

• 2) Sajid MS, Ladwa N, Kalra L et al : Single-Incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy : Meta-analysis and Systematic Review of Randomized Controlled Trials. World J Surg 36 (11) : 2644-2653, 2012
  pubmed

• 3) Trastulli S, Cirocchi R, Desiderio J et al : Systematic review and meta-analysis of randomized clinical trials comparing single-incision versus conventional laparoscopic cholecystectomy. Br J Surg 100 (2) : 191-208, 2013
  pubmed

• 4) Dauser B, Gorgei A, Stopfer J et al : Conventional laparoscopy vs. single port surgery from a patient's point of view : influence of demographics and body mass index. Wien Klin Wochenschr 124 (23-24) : 834-841, 2012

• 5) Lee WS, Choi ST, Lee JN et al : Single-Port Laparoscopic Appendectomy Versus Conventional Laparoscopic Appendectomy : A Prospective Randomized Controlled Study. Ann Surg 257 (2) : 214-218, 2013
  pubmed

• 6) Teoh AY, Chiu PW, Wong TC et al : A double-blinded randomized controlled trial of laparoendoscopic single-site access versus conventional 3-port appendectomy. Ann Surg 256 (6) : 909-914, 2012
  pubmed

• 7) Perez EA, Piper H, Burkhalter LS et al : Single-incision laparoscopic surgery in children : a randomized control trial of acute appendicitis. Surg Endosc, 2012 (10.1007/s00464-012-2617-5)

• 8) Rehman H, Mathews T, Ahmed I : A review of minimally invasive single-port/incision laparoscopic appendectomy. J Laparoendosc Adv Surg Tech A 22 (7) : 641-646, 2012

P.171 掲載の参考文献

• 9) Soon Y, Yip E, Onida S et al : Single-port hernia repair : a prospective cohort of 102 patients. Hernia 16 (4) : 393-396, 2012
  pubmed

• 10) Shih TY, Wen KC, Lin KY et al : Transumbilical, single-port, totally extraperitoneal, laparoscopic inguinal hernia repair using a homemade port and a conventional instrument : an initial experience. J Laparoendosc Adv Surg Tech A 22 (2) : 162-164, 2012

• 11) Fuentes MB, Goel R, Lee-Ong AC et al : Single-port endo-laparoscopic surgery (SPES) for totally extraperitoneal inguinal hernia : a critical appraisal of the chopstick repair. Hernia, 2012 (doi : 10.1007/s10029-012-0968-4)

• 12) Chang YT, Lin JY, Lee JY et al : Comparative Mid-term Results Between Inguinal Herniotomy and Single-port Laparoscopic Herniorrhaphy for Pediatric Inguinal Hernia. Surg Laparosc Endosc Percutan Tech 22 (6) : 526-531, 2012
  pubmed

• 13) Gronvold LB, Spasojevic M, Nesgaard JM et al : Single-incision laparoscopic versus conventional laparoscopic ventral hernia repair : a comparison of short-term surgical results. Surg Laparosc Endosc Percutan Tech 22 (4) : 354-357, 2012
  pubmed

• 14) Kunisaki C, Ono HA, Oshima T et al : Relevance of reduced-port laparoscopic distal gastrectomy for gastric cancer : a pilot study. Dig Surg 29 (3) : 261-268, 2012
  pubmed

• 15) Takahashi T, Takeuchi H, Kawakubo H et al : Single-incision laparoscopic surgery for partial gastrectomy in patients with a gastric submucosal tumor. Am Surg 78 (4) : 447-450, 2012
  pubmed

• 16) Makino T, Milsom JW, Lee SW : Single-incision laparoscopic surgeries for colorectal diseases : early experiences of a novel surgical method. Minim Invasive Surg, 2012 (doi : 10.1155/2012/783074)

• 17) Fung AK, Aly EH : Systematic review of single-incision laparoscopic colonic surgery. Br J Surg 99 (10) : 1353-1364, 2012
  pubmed

• 18) Aikawa M, Miyazawa M, Okamoto K et al : Single-port laparoscopic hepatectomy : technique, safety, and feasibility in a clinical case series. Surg Endosc 26 (6) : 1696-1701, 2012

• 19) Misawa T, Ito R, Futagawa Y et al : Single-incision laparoscopic distal pancreatectomy with or without splenic preservation : how we do it. Asian J Endosc Surg 5 (4) : 195-199, 2012
  pubmed

P.172 掲載の参考文献

• 20) Wronski M, Cebulski W, Slodkowski M et al : Retroperitoneal minimally invasive pancreatic necrosectomy using single-port access. Surg Laparosc Endosc Percutan Tech 22 (1) : e8-11, 2012

• 21) Monclova JL, Targarona EM, Vidal P et al : Single incision versus reduced port splenectomy-searching for the best alternative to conventional laparoscopic splenectomy. Surg Endosc 27 (3) : 895-902, 2013
  pubmed

• 22) Chakravartty S, Murgatroyd B, Ashton D et al : Single and multiple incision laparoscopic adjustable gastric banding : a matched comparison. Obes Surg. 22 (11) : 1695-1700, 2012
  pubmed

• 23) Dapri G, El Mourad H, Mathonet P et al : Single-access laparoscopic adjustable gastric band removal : Technique and initial experience. Obes Surg 23 (2) : 272-276, 2013
  pubmed

• 24) Huang CK, Lo CH, Houng JY et al : Surgical results of single-incision transumbilical laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 8 (2) : 201-207, 2012
  pubmed

• 25) Nguyen NT, Smith BR, Reavis KM et al : Strategic laparoscopic surgery for improved cosmesis in general and bariatric surgery : analysis of initial 127 cases. J Laparoendosc Adv Surg Tech A. 22 (4) : 355-361, 2012

• 26) John PH, Thanakumar J, Krishnan A : Reduced port laparoscopic repair of Bochdalek hernia in an adult : A first report. J Minim Access Surg 8 (4) : 158-160, 2012

• 27) Kodera Y : Reduced port surgery for gastric cancer : another giant leap for mankind? Gastric Cancer, 2012 (doi : 10.1007/s10120-012-0221-y)

• 28) Kawamura H, Tanioka T, Kuji M et al : The initial experience of dual port laparoscopy-assisted total gastrectomy as a reduced port surgery for total gastrectomy. Gastric Cancer, 2012 (doi : 10.1007/s10120-012-0212-z)

• 29) Lim SW, Kim HJ, Kim CH et al : Umbilical incision laparoscopic colectomy with one additional port for colorectal cancer. Tech Coloproctol, 2012 (doi : 10.1007/s10151-012-0900-z)

P.173 掲載の参考文献

• 30) Lim MS, Melich G, Min BS : Robotic single-incision anterior resection for sigmoid colon cancer : access port creation and operative technique. Surg Endosc 27 (3) : 1021, 2013
  pubmed

P.175 掲載の参考文献

• 1) 阿部雄太, 高野公徳, 粕谷和彦, 他 : 肝切除における画像支援手術. 臨床外科 66 (8) : 1040-1050, 2012

• 2) Lamata P, Lamata F, Sojar V et al : Use of the Resection Map system as guidance during hepatectomy. Surg Endosc 24 (9) : 2327-2337, 2010
  pubmed

• 3) Mise Y, Tani K, Aoki T et al : Virtual liver resection : computer-assisted operation planning using a three-dimensional liver representation. J Hepatobiliary Pancreat Sci 20 (2) : 157-164, 2013
  pubmed

P.176 掲載の参考文献

• 4) Hansen C, Black D, Lange C et al : Auditory support for resection guidance in navigated liver surgery. Int J Med Robot, 2012 (doi : 10.1002/rcs.1466)

• 5) Sugimoto M, Yasuda H, Koda K et al : Image overlay navigation by markerless surface registration in gastrointestinal, hepatobiliary and pancreatic surgery. J Hepatobiliary Pancreat Sci 17 (5) : 629-636, 2009
  pubmed

P.177 掲載の参考文献

• 6) Ieiri S, Uemura M, Konishi K et al : Augmented reality navigation system for laparoscopic splenectomy in children based on preoperative CT image using optical tracking device. Pediatr Surg Int 28 (4) : 341-346, 2012
  pubmed

• 7) Okamoto T, Onda S, Matsumoto M et al : Utility of augmented reality system in hepatobiliary surgery. J Hepatobiliary Pancreat Sci 20 (2) : 249-253, 2013
  pubmed

• 8) Onda S, Okamoto T, Kanehira M et al : Short rigid scope and stereo-scope designed specifically for open abdominal navigation surgery : clinical application for hepatobiliary and pancreatic surgery. J Hepatobiliary Pancreat Sci, 2012 (doi : 10.1007/s00534-012-0582-y)

• 9) Azagury DE, Ryou M, Shaikh SN et al : Real-time computed tomography-based augmented reality for natural orifice transluminal endoscopic surgery navigation. Br J Surg 99 (9) : 1246-1253, 2012
  pubmed

• 10) 草野満夫 編 : "ICG蛍光Navigation Surgeryのすべて", インターメディカ社, 東京, 2008

• 11) 河地茂行, 田邉 稔, 篠田昌宏, 他 : 肝区域のTattooingと腫瘍のMarking-胆嚢癌の至適肝切除範囲の同定LED 励起ICG蛍光により同定した胆嚢静脈灌流域を切除する胆嚢癌に対する拡大胆嚢摘出術の1例. "ICG蛍光Navigation Surgeryのすべて" (草野満夫 編), インターメディカ, 東京, pp349-354, 2008

• 12) 多賀谷信美, 阿部曉人, 窪田敬一 : ICG術中蛍光胆道検索を併用した単孔式腹腔鏡下胆嚢摘出術-手術手技のコツおよび非併用例との比較-. 胆道 25 (4) : 619-625, 2011
  Medical*Online

• 13) Kaburagi T, Takeuchi H, Oyama T et al : Intraoperative fluorescence lymphography using indocyanine green in a patient with chylothorax after esophagectomy : report of a case. Surg Today 43 (2) : 206-210, 2013

P.178 掲載の参考文献

• 14) 二村浩史, 高橋直人, 渡部篤史 他 : 赤外線腹腔鏡システムを用いたテーラーメイド胃癌治療. リンパ学 32 (2) : 91-96, 2009
  Medical*Online

• 15) Handa T, Katare RG, Nishimori H et al : New device for intraoperative graft assessment : HyperEye charge-coupled device camera system. Gen Thorac Cardiovasc Surg 58 (2) : 68-77, 2010
  pubmed

• 16) 杉本健樹, 花崎和弘, 佐藤隆幸 : Hyper Eye Medical Systemを用いた乳癌センチネルリンパ節生検手技. 手術 65 : 421-425, 2011

• 17) 中村哲也, 吉田昌, 北島政樹 他 : ハイパーアイメディカルシステム (Hyper Eye Medical System ; HEMS) の腹部外科への応用. Prog Med 31 : 806-809, 2011
  Medical*Online

• 18) Kubota K, Yoshida M, Kuroda J et al : Application of the HyperEye Medical System for esophageal cancer surgery : a preliminary report. Surg Today 43 (2) : 215-220, 2013
  pubmed

• 19) Takeuchi H, Kawakubo H, Takeda F, et al : Sentinel node navigation surgery in early-stage esophageal cancer. Ann Thorac Cardiovasc Surg 18 : 306-313, 2012
  pubmed

• 20) Kitagawa Y, Mukai M, Nakahara T et al : Clinical significance of molecular metastasis in sentinel lymph nodes of esophageal cancer. Esophagus 4 : 19-22, 2007

P.179 掲載の参考文献

• 21) Miyashiro I : What is the problem in clinical application of sentinel node concept to gastric cancer surgery? J Gastric Cancer 12 (1) : 7-12, 2012
  pubmed

• 22) Bok GH, Kim YJ, Jin SY et al : Endoscopic submucosal dissection with sentinel node navigation surgery for early gastric cancer. Endoscopy 44 (10) : 953-956, 2012
  pubmed

• 23) Bharathan R, Aggarwal R, Darzi A : Operating room of the future. Best Pract Res Clin Obstet Gynaecol, 2012 (doi : 10.1016/j.bpobgyn.2012.11.003)

P.180 掲載の参考文献

• 1) Joensuu H, Vehtari A, Riihimaki J et al : Risk of recurrence of gastrointestinal stromal tumour after surgery : an analysis of pooled population-based cohorts. Lancet Oncol 13 (3) : 265-274, 2012
  pubmed

• 2) George S, Reichardt P, Lechner T et al : Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib. Ann Oncol 23 (12) : 3180-3187, 2012
  pubmed

• 3) Rutkowski P, Bylina E, Klimczak A et al : The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC Cancer 12 : 107, 2012
  pubmed

P.181 掲載の参考文献

• 4) Lagarde P, Perot G, Kauffmann A et al : Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res 18 (3) : 826-838, 2012
  pubmed

• 5) Bertucci F, Finetti P, Ostrowski J et al : Genomic Grade Index predicts postoperative clinical outcome of GIST. Br J Cancer 107 (8) : 1433-1441, 2012
  pubmed

• 6) Miranda C, Nucifora M, Molinari F et al : KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res 18 (6) : 1769-1776, 2012
  pubmed

• 7) Kim WK, Park M, Kim YK et al : MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res 17 (24) : 7584-7594, 2012

• 8) Niinuma T, Suzuki H, Nojima M et al : Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 72 (5) : 1126-1136, 2012
  pubmed

• 9) De Vogelaere K, Hoorens A, Haentjens P, et al : Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach. Surg Endosc, 2012 (doi : 10.1007/s00464-012-2622-8)

P.182 掲載の参考文献

• 10) De Vogelaere K, Van Loo I, Peters O et al : Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size. Surg Endosc 26 (8) : 2339-2345, 2012
  pubmed

• 11) Wu SD, Kong J, Su Y et al : Safety and application of transumbilical single-incision laparoscopic gastrectomy for GIST : SILS in benign gastric disease. Surg Innov, 2012 (doi : 10.1177/1553350612455224)

• 12) Liu BR, Song JT, Qu B et al : Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria. Surg Endosc 26 (11) : 3141-3148, 2012
  pubmed

• 13) Turley RS, Peng PD, Reddy SK et al : Pawlik TM, Clary BM. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer 118 (14) : 3571-3578, 2012
  pubmed

• 14) Joensuu H, Eriksson M, Sundby Hall K et al : One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor : a randomized trial. JAMA 307 (12) : 1265-1272, 2012
  pubmed

• 15) Blanke CD : Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors. JAMA 307 (12) : 1312-1314, 2012
  pubmed

P.183 掲載の参考文献

• 16) Tielen R, Verhoef C, van Coevorden F et al : Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol 39 (2) : 150-155, 2012
  pubmed

• 17) Wang D, Zhang Q, Blanke CD et al : Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors : long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol 19 (4) : 1074-1080, 2012

• 18) McCarter MD, Antonescu CR, Ballman KV et al : Microscopically positive margins for primary gastrointestinal stromal tumors : analysis of risk factors and tumor recurrence. J Am Coll Surg 215 (1) : 53-59 ; discussion 59-60, 2012

• 19) George S, Wang Q, Heinrich MC et al : Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib : a multicenter phase II trial. J Clin Oncol 30 (19) : 2401-2407, 2012

• 20) Demetri GD, Reichardt P, Kang YK et al : Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID) : an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381 (9863) : 295-302, 2012
  pubmed

• 21) Reichardt P, Blay JY, Gelderblom H et al : Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib. Ann Oncol 23 (7) : 1680-1687, 2012

P.184 掲載の参考文献

• 22) Heinrich MC, Marino-Enriquez A, Presnell A et al : Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors. Mol Cancer Ther 11 (8) : 1770-1780, 2012
  pubmed

• 23) Park SH, Ryu MH, Ryoo BY et al : Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors : a phase II study of Korean gastrointestinal stromal tumors study group. Invest New Drugs 30 (6) : 2377-2383, 2012
  pubmed

• 24) Montemurro M, Gelderblom H, Bitz U et al : Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib : A retrospective analysis. Eur J Cancer, 2012 (doi : 10.1016/j.ejca.2012.10.009)
  pubmed

• 25) Patrikidou A, Chabaud S, Ray-Coquard I et al : Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST : results of the BFR14 prospective French Sarcoma Group randomised, phase III trial. Ann Oncol, 2012 (doi : 10.1093/annonc/mds587)

• 26) Cassier PA, Fumagalli E, Rutkowski P et al : Outcome of patients with plateletderived growth factor receptor alphamutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Clin Cancer Res 18 (16) : 4458-4464, 2012
  pubmed

• 27) Heinrich MC, Griffith D, McKinley A et al : Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors. Clin Cancer Res 18 (16) : 4375-4384, 2012
  pubmed

P.185 掲載の参考文献

• 28) Smyth T, Van Looy T, Curry JE et al : The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models. Mol Cancer Ther 11 (8) : 1799-1808, 2012
  pubmed

• 29) Dickson MA, Okuno SH, Keohan ML et al : Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors. Ann Oncol 24 (1) : 252-257, 2013
  pubmed

• 30) Floris G, Wozniak A, Sciot R et al : A Potent combination of the novel PI3K inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts : Long-lasting responses after treatment withdrawal. Clin Cancer Res 19 (3) : 620-630, 2013

P.186 掲載の参考文献

• 1) 北野正剛, 山下裕一, 白石憲男 他 : 内視鏡外科手術に関するアンケート調査-第11回集計結果報告 (日本内視鏡外科学会). 日本内視鏡外科学会雑誌 17 (5) : 571-694, 2012

• 2) 北野正剛, 山下裕一, 白石憲男 他 : 日本内視鏡外科学会 内視鏡外科手術に関するアンケート調査 第10回集計結果報告. 日本内視鏡外科学会雑誌 15 (5) : 565-679, 2010

P.187 掲載の参考文献

• 3) Dagher I, O'Rourke N, Geller DA et al : Laparoscopic major hepatectomy : an evolution in standard of care. Ann Surg 250 (5) : 856-860, 2009
  pubmed

• 4) Nitta H, Sasaki A, Otsuka Y et al : Impact of hybrid techniques on laparoscopic major hepatectomies. J Hepatobiliary Pancreat Sci 20 (2) : 111-113, 2013
  pubmed

• 5) Tzanis D, Shivathirthan N, Laurent A et al : European experience of laparoscopic major hepatectomy. J Hepatobiliary Pancreat Sci 20 (2) : 120-124, 2013
  pubmed

• 6) Hwang DW, Han HS, Yoon YS et al : Laparoscopic major liver resection in Korea : a multicenter study. J Hepatobiliary Pancreat Sci 20 (2) : 125-130, 2013
  pubmed

• 7) Lin NC, Nitta H, Wakabayashi G : Laparoscopic major hepatectomy : A systematic literature review and comparison of 3 techniques. Ann Surg 257 (2) : 205-213, 2013
  pubmed

• 8) Ishizawa T, Gumbs AA, Kokudo N et al : Laparoscopic segmentectomy of the liver : from segment I to VIII. Ann Surg 256 (6) : 959-964, 2012
  pubmed

• 9) Spampinato MG, Arvanitakis M, Puleo F et al : Totally laparoscopic liver resections for primary and metastatic cancer in the elderly : safety, feasibility and short-term outcomes. Surg Endosc, 2012 (doi : 10.1007/s00464-012-2687-4)

• 10) Tsuchiya M, Otsuka Y, Maeda T et al : Efficacy of laparoscopic surgery for recurrent hepatocellular carcinoma. Hepatogastroenterology 59 (117) : 1333-1337, 2012
  pubmed

P.188 掲載の参考文献

• 11) Conrad C, Shivathirthan N, Camerlo A et al : Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg 256 (3) : e14-5 ; author reply e16-7, 2012

• 12) Machado MA, Makdissi FF, Surjan RC : Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg 256 (3) : e13 ; author reply e16-9, 2012

• 13) Ho CM, Wakabayashi G, Nitta H et al : Total laparoscopic limited anatomical resection for centrally located hepatocellular carcinoma in cirrhotic liver. Surg Endosc, 2012 (doi : 10.1007/s00464-012-2624-6)

• 14) Giulianotti PC, Tzvetanov I, Jeon H et al : Robot-assisted right lobe donor hepatectomy. Transpl Int 25 (1) : e5-9, 2012

• 15) Trastulli S, Cirocchi R, Desiderio J et al : Systematic review and meta-analysis of randomized clinical trials comparing single-incision versus conventional laparoscopic cholecystectomy. Br J Surg 100 (2) : 191-208, 2013
  pubmed

P.189 掲載の参考文献

• 16) Yokoe M, Takada T, Strasberg SM et al : TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 20 : 35-46, 2013
  pubmed

• 17) Yamashita Y, Takada T, Strasberg SM et al : TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci 20 : 89-96, 2013
  pubmed

• 18) Asai K, Watanabe M, Kusachi S et al : Changes in the therapeutic strategy for acute cholecystitis after the Tokyo guidelines were published. J Hepatobiliary Pancreat Sci 20 : 348-355, 2013
  pubmed

• 19) Gurusamy K, Samraj K, Gluud C et al : Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 97 (2) : 141-150, 2010
  pubmed

• 20) Banz V, Gsponer T, Candinas D et al : Population-based analysis of 4113 patients with acute cholecystitis : defining the optimal time-point for laparoscopic cholecystectomy. Ann Surg 254 : 964-970, 2011
  pubmed

• 21) 山下裕一, 乗富智明, 松岡信秀 他 : 【急性胆管炎・胆嚢炎の診療ガイドラインを検証する-改訂に向けてのプロセスと課題-】急性胆嚢炎に対する腹腔鏡下胆嚢摘出術は推奨治療になったか. 日本腹部救急医学会雑誌 32 (3) : 651-656, 2012

• 22) de Goede B, Klitsie PJ, Hagen SM et al : Meta-analysis of laparoscopic versus open cholecystectomy for patients with liver cirrhosis and symptomatic cholecystolithiasis. Br J Surg 100 (2) : 209-216, 2013
  pubmed

P.190 掲載の参考文献

• 23) Nakamura M, Nakashima H : Laparoscopic distal pancreatectomy and pancreatoduodenectomy : is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J Hepatobiliary Pancreat Sci, 2012 (doi : 10.0007/s00534-012-0578-7)

• 24) Asbun HJ, Stauffer JA : Laparoscopic vs open pancreaticoduodenectomy : overall outcomes and severity of complications using the Accordion Severity Grading System. J Am Coll Surg 215 (6) : 810-819, 2012
  pubmed

• 25) 山口幸二, 皆川紀剛 : 日本膵臓学会膵癌診療ガイドライン改訂委員会 膵癌診療の最近の動向とガイドライン改訂に向けて "Annual review 消化器 2012", 中外医学社, pp242-247, 2012

• 26) Strijker M, van Santvoort HC, Besselink MG et al : Robot-assisted pancreatic surgery : a systematic review of the literature. HPB (Oxford) 15 (1) : 1-10, 2013
  pubmed

• 27) Daouadi M, Zureikat AH, Zenati MS et al : Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg 257 (1) : 128-32, 2013

P.191 掲載の参考文献

• 28) Musallam KM, Khalife M, Sfeir PM et al : Postoperative outcomes after laparoscopic compared with open splenectomy. Ann Surg. 2012 Nov 30. [Epub ahead of print] PubMed PMID : 23207245. DOI : 10.1097/SLA.0b013e318275496a

• 29) Winslow ER, Brunt LM : Perioperative outcomes of laparoscopic versus open splenectomy : a meta-analysis with an emphasis on complications. Surgery 134 (4) : 647-653 ; discussion 654-65, 2003

• 30) Monclova JL, Targarona EM, Vidal P et al : Single incision versus reduced port splenectomy-searching for the best alternative to conventional laparoscopic splenectomy. Surg Endosc 27 (3) : 895-902, 2013
  pubmed

II章

P.196 掲載の参考文献

• 1) Anastas JN, Moon RT : WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13 : 11-26, 2012

• 2) Fu L, Zhang C, Zhang LY et al : Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut 60 : 1635-1643, 2011

• 3) Yu M, Ting DT, Stott SL et al : RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487 : 510-513, 2012
  pubmed

• 4) Tenbaum SP, Ordonez-Moran P, Puig I et al : β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 18 : 892-901, 2012

P.197 掲載の参考文献

• 5) Ocana OH, Corcoles R, Fabra A et al : Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22 : 709-724, 2012
  pubmed

• 6) Tsai JH, Donaher JL, Murphy DA et al : Spatiotemporal regulation of epithelialmesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22 : 725-736, 2012
  pubmed

• 7) Weis SM, Cheresh DA : Tumor angiogenesis : molecular pathways and therapeutic targets. Nat Med 17 : 1359-1370, 2011
  pubmed

• 8) Zhang W, Sun HC, Wang WQ et al : Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. Gastroenterology 143 : 1641-1649, 2012
  pubmed

P.198 掲載の参考文献

• 9) Maione F, Capano S, Regano D et al : Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest 122 : 1832-1848, 2012
  pubmed

• 10) Rapisarda A, Melillo G : Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat Rev Clin Oncol 9 : 378-390, 2012
  pubmed

• 11) Kong YW, Ferland-McCollough D, Jackson TJ et al : microRNAs in cancer management. Lancet Oncol 13 : e249-258, 2012
  pubmed

• 12) Lujambio A, Lowe SW : The microcosmos of cancer. Nature 482 : 347-355, 2012
  pubmed

• 13) Yang WH, Lan HY, Huang CH et al : RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 14 : 366-374, 2012
  pubmed

P.199 掲載の参考文献

• 14) Bao W, Fu HJ, Xie QS et al : HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology 141 : 2076-2087, 2011
  pubmed

• 15) Sampieri K, Fodde R : Cancer stem cells and metastasis. Semin Cancer Biol 22 : 187-193, 2012
  pubmed

• 16) Vermeulen L, de Sousa e Melo F, Richel DJ et al : The developing cancer stem-cell model : clinical challenges and opportunities. Lancet Oncol 13 : e83-89, 2012
  pubmed

• 17) Maliar A, Servais C, Waks T et al : Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice. Gastroenterology 143 : 1375-1384, 2012
  pubmed

P.200 掲載の参考文献

• 18) Qian YW, Chen Y, Yang W et al : p28 (GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology 142 : 1547-1558, 2012

• 19) Rothwell PM, Wilson M, Price JF et al : Effect of daily aspirin on risk of cancer metastasis : a study of incident cancers during randomised controlled trials. Lancet 379 : 1591-1601, 2012
  pubmed

• 20) Chan AT, Cook NR : Are we ready to recommend aspirin for cancer prevention? Lancet 379 : 1569-1571, 2012
  pubmed

P.202 掲載の参考文献

• 1) Chiba T, Marusawa H, Ushijima T : Inflammation-associated cancer development in digestive organs : mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143 (3) : 550-563, 2012
  pubmed

• 2) Sinkovics JG : Molecular biology of oncogenic inflammatory processes. I. Nononcogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review).Int J Oncol 40 (2) : 305-349, 2012
  pubmed

• 3) Hu Y, Ericsson I, Torseth K et al : A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching. J Mol Biol, 2012 (doi : 10.1016/j.jmb.2012.11.026)

• 4) Prud'homme GJ : Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des 18 (19) : 2838-2849, 2012

• 5) Sampieri K, Fodde R : Cancer stem cells and metastasis. Semin Cancer Biol 22 (3) : 187-193, 2012
  pubmed

P.203 掲載の参考文献

• 6) Feng Y, Dai X, Li X et al : EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif 45 (5) : 413-419, 2012

• 7) Gupta PB, Onder TT, Jiang G et al : Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138 (4) : 645-659, 2009
  pubmed

• 8) Adikrisna R, Tanaka S, Muramatsu S et al : Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 143 (1) : 234-245.e7, 2012

• 9) Li SQ, Wang HM, Cao XF : Potential clinical insights into microRNAs and their target genes in esophageal carcinoma. Biomarkers 16 (8) : 629-636, 2011
  pubmed

• 10) Allegra A, Alonci A, Campo S et al : Circulating microRNAs : New biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol, 2012 (doi : 10.3892/ijo.2012.1647)

• 11) Che X, Huang C : microRNA, Cancer and Cancer Chemoprevention. Curr Mol Pharmacol, 2012 (PubMed ID : 22697394)

• 12) Burn J, Mathers J, Bishop DT : Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res 191 : 157-183, 2013
  pubmed

P.204 掲載の参考文献

• 13) Thiel A, Ristimaki A : Gastric cancer : basic aspects. Helicobacter 17 (Suppl 1) : 26-29, 2012

• 14) Song JH, Meltzer SJ : MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143 (1) : 35-47, 2012
  pubmed

• 15) Schoof CR, Botelho EL, Izzotti A et al : MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2 (4) : 414-433, 2012
  pubmed

• 16) Mikko S : Interactions of alcohol and tobacco in gastrointestinal cancer. J Gastroenterol Hepatol 27 (Suppl 2) : 135-139, 2012

• 17) Chiang CP, Jao SW, Lee SP et al : Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel : association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer. Alcohol 46 (1) : 37-49, 2012
  pubmed

• 18) Mazaki T, Masuda H, Takayama T : Polymorphisms and pancreatic cancer risk : a meta-analysis. Eur J Cancer Prev 20 (3) : 169-183, 2011

P.205 掲載の参考文献

• 19) Bellini MF, Cadamuro AC, Succi M et al : Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol 891961, 2012
  pubmed

• 20) Wei Y, Liu F, Li B et al : Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk : a HuGE systematic review and meta-analysis. Dig Dis Sci 56 (8) : 2227-2236, 2011

• 21) Zhou JY, Shi R, Yu HL et al : The association between two polymorphisms in the TS gene and risk of cancer : a systematic review and pooled analysis. Int J Cancer 131 (9) : 2103-2116, 2012

• 22) Di Francia R, Siesto RS, Valente D et al : Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy. Eur Rev Med Pharmacol Sci. 16 (9) : 1211-1217, 2012
  pubmed

• 23) Morita S, Uehara K, Nakayama G et al : Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer. Cancer Chemother Pharmacol 71 (2) : 405-411, 2013
  pubmed

P.206 掲載の参考文献

• 24) Khare S, Verma M : Epigenetics of colon cancer. Methods Mol Biol. 863 : 177-185, 2012
  pubmed

• 25) Agarwal A, Polineni R, Hussein Z et al : Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol 5 (5) : 382-396, 2012
  pubmed

• 26) Podolska K, Stachurska A, Hajdukiewicz K et al : Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med 21 (4) : 525-534, 2012
  pubmed

• 27) Carson AR, McTiernan CF, Lavery L et al : Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 72 (23) : 6191-6199, 2012
  pubmed

P.207 掲載の参考文献

• 28) Jagani H, Rao JV, Palanimuthu VR et al : A nanoformulation of siRNA and its role in cancer therapy : In vitro and in vivo evaluation. Cell Mol Biol Lett 18 (1) : 120-136, 2013
  pubmed

• 29) Zhou J, Shi YH, Fan J : Circulating cell-free nucleic acids : promising biomarkers of hepatocellular carcinoma. Semin Oncol 39 (4) : 440-448, 2012

• 30) Corso G, Marrelli D, Pascale V : Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas : metanalysis and systematic review of the literature. BMC Cancer 12 : 8, 2012
  pubmed

• 31) Thiel A, Mrena J, Ristimaki A : Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev. 30 (3-4) : 387-395, 2011

• 32) Shimada R, Iinuma H, Tamura J et al : Usefulness of CTCs in tumor drainage vein blood as a biomarker for prognosis in colorectal cancer patients with Dukes' stage B and C. Gan To Kagaku Ryoho 39 (12) : 1763-1765, 2012

• 33) Waligorska-Stachura J, Jankowska A, Wasko R et al : Survivin--prognostic tumor biomarker in human neoplasms--review. Ginekol Pol 83 (7) : 537-540, 2012
  pubmed

P.208 掲載の参考文献

• 1) Ando N, Kato H, Igaki H et al : A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19 : 68-74, 2012

• 2) Hurt CN, Nixon LS, Griffiths GO et al : SCOPE1 : a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer 11 : 466, 2011
  pubmed

P.209 掲載の参考文献

• 3) van Hagen P, Hulshof MC, van Lanschot JJ et al : Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366 : 2074-2084, 2012

• 4) Conroy T, Galais MP, Raoul JL et al : Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC) : Final results of the PRODIGE 5/ACCORD 17 trial. J Clin Oncol 30 : 2012 (suppl ; abstr 4003), 2012
  pubmed

• 5) Iwase H, Shimada M, Tsuzuki T et al : A phase II trial of definitive chemoradiotherapy with S-1 and cisplatin for locally advanced oesophageal cancer. Ann Oncol 23 : 2012 (suppl 9 ; abstr 671P), 2012

• 6) Sasako M, Sakuramoto S, Katai H et al : Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29 : 4387-4393, 2011
  pubmed

• 7) Takahari D, Hamaguchi T, Yoshimura K et al : Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. Cancer Chemother Pharmacol 67 : 1423-1428, 2011

P.210 掲載の参考文献

• 8) Bang YJ, Kim YW, Yang HK : Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC) : a phase 3 open-label, randomised controlled trial. Lancet 379 : 315-321, 2012
  pubmed

• 9) Sawaki A, Ohashi Y, Omuro Y et al : Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer : a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer 15 : 313-322, 2012
  pubmed

• 10) Yoshida K, Fujii M, Koizumi W et al : S-1 plus docetaxel versus S-1 for advanced gastric cancer (START trial) update 2012 (JACCRO and KCSG study group). Ann Oncol 23 : 2012 (suppl 9 ; abstr LBA19PR), 2012

P.211 掲載の参考文献

• 11) Thuss-Patience PC, Kretzschmar A, Bichev D et al : Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur J Cancer 47 : 2306-2314, 2011

• 12) Kang JH, Lee SI, Lim do H et al : Salvage chemotherapy for pretreated gastric cancer : a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J Clin Oncol 30 : 1513-1518, 2012
  pubmed

• 13) "胃癌治療ガイドライン速報 (2012年11月)" http://www.jgca.jp/pdf/GL201211.pdf

• 14) Ueda S, Hironaka S, Yasui H : Randomized phase III study of irinotecan (CPT-11) versus weekly paclitaxel (wPTX) for advanced gastric cancer (AGC) refractory to combination chemotherapy (CT) of fluoropyrimidine plus platinum (FP) : WJOG4007 trial. J Clin Oncol 30 : 2012 (suppl ; abstr 4002), 2012

• 15) Sanoff HK, Carpenter WR, Sturmer T et al : Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 30 : 2624-2634, 2012
  pubmed

• 16) Haller DG, O'Connell M, Thomas H et al : Impact of age and medical comorbidity (MC) on adjuvant treatment outcomes for stage III colon cancer (CC) : A pooled analysis of individual patient data from four randomized controlled trials. J Clin Oncol 30 : 2012 (suppl ; abstr 3522), 2012

• 17) Tournigand C, Andre T, Bonnetain F et al : Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer : subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 30 : 3353-3360, 2012

P.212 掲載の参考文献

• 18) Shimada Y, Hamaguchi T, Moriya Y et al : Randomized phase III study of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients (pts) with stage III colon cancer (CC) : Final results of Japan Clinical Oncology Group study (JCOG0205). J Clin Oncol 30 : 2012 (suppl ; abstr 3524), 2012

• 19) Kondo K, Sadahiro S, Tsuchiya T et al : Phase III trial of treatment duration for oral uracil and tegaful/leukovorin adjuvant chemotherapy for patients (pts) with stage IIb/III colon cancer : result of JFMC33-0502. Ann Oncol 23 : 2012 (suppl 9 ; abstr 552P), 2012

• 20) Hong YS, Park YS, Lim HY et al : S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer : a randomised, non-inferiority phase 3 trial. Lancet Oncol 13 : 1125-1132, 2012
  pubmed

• 21) Baba H, Watanabe M, Okabe H et al : Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer. Br J Cancer 107 : 1950-1955, 2012
  pubmed

P.213 掲載の参考文献

• 22) Arnold D, Andre T, Bennouna J et al : Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT : Results of a randomized phase III intergroup study (TML study). J Clin Oncol 30 : 2012 (suppl ; abstr 3503), 2012

• 23) Osterlund P, Alonso-Orduna V, Schlichting C et al : bevacizumab (BEV) + chemotherapy (CT) beyond first progression in patients (PTS) with metastatic colorectal cancer (MCRC) previously treated with first-line BEV+CT (ML18147) : efficacy and safety analyses by oxaliplatin vs irinotecan-based CT. Ann Oncol 23 : 2012 (suppl 9 ; abstr 571P), 2012

• 24) McCahill LE, Yothers G, Sharif S et al : Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer : definitive analysis of NSABP trial C-10. J Clin Oncol 30 : 3223-3228, 2012

• 25) Faron M, Bourredjem A, Pignon JP et al : Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis : Pooled analysis of individual patients' data from four randomized trials. J Clin Oncol 30 : 2012 (suppl ; abstr 3507) 2012

• 26) Tournigand C, Samson B, Scheithauer W et al : Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction firstline chemotherapy plus Bev, in patients (pts) with metastatic colorectal cancer (mCRC) : Efficacy and safety results of the International GERCOR DREAM phase III trial. J Clin Oncol 30 : 2012 (suppl ; abstr 3507), 2012

• 27) Van Cutsem E, Sobrero AF, Siena S et al : Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC). J Clin Oncol 30 : 2012 (suppl ; abstr 3507) 2012

P.214 掲載の参考文献

• 28) Yoshino T, Mizunuma N, Yamazaki K et al : TAS-102 monotherapy for pretreated metastatic colorectal cancer : a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 13 : 993-1001, 2012
  pubmed

• 29) Schmoll HJ, Van Cutsem E, Stein A et al : ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23 : 2503-2504, 2012

• 30) Nordlinger B, Sorbye H, Glimelius B et al : EORTC liver metastases intergroup randomized phase III study 40983 : Long-term survival results. J Clin Oncol 30 : 2012 (suppl ; abstr 3508), 2012

P.215 掲載の参考文献

• 1) 日本肝臓学会 編 : "科学的根拠に基づく肝癌診療ガイドライン (2009年版)", 金原出版, 東京, 2009

P.216 掲載の参考文献

• 2) Llovet JM, Ricci S, Mazzaferro V et al : Solafenib in advanced hepatocelluar carcinoma. N Engl J Med 359 : 378-390, 2008

• 3) Cheng AL, Kang YK, Chen Z et al : Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10 (1) : 25-34, 2009

• 4) Printz C : Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer 115 (20) : 4646, 2009
  pubmed

P.217 掲載の参考文献

• 5) Santoro A, Rimassa L, Borbath I et al : Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study. Lancet Oncol 14 (1) : 55-63, 2013
  pubmed

• 6) Takada T, Amano H, Yasuda H et al : Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95 : 1685-1695, 2002
  pubmed

• 7) Glimelius B, Hoffrnan K, Sjoden PO et al : Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7 : 593-600, 1996

• 8) Raderer M, Hejna MH, Valencak JB et al : Two consecutive Phase II study of 5fluorouracil/leu-covorin/mitomycin C and of gemchabine in patients with advanced biliary cancer. Oncology 56 : 177-180, 1999

• 9) Jang JS, Lim HY, Hwang IG et al : Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer : a Korean Cancer Study Group phase II trial. Cancer Chemother Pharmacol 65 (4) : 641-647, 2010

• 10) Gruenberger B, Schueller J, Heubrandtner U et al : Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer : a phase 2 study. Lancet Oncol 11 (12) : 1142-1148, 2010
  pubmed

• 11) Bekaii-Saab T, Phelps MA, Li X et al : Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers. J Clin Oncol 29 (17) : 2357-2363, 2011
  pubmed

• 12) Chung MJ, Kim YJ, Park JY et al : Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer. Chemotherapy 57 (3) : 236-243, 2011
  pubmed

• 13) Kim KP, Jang G, Hong YS et al : Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer : influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity. Br J Cancer 104 (4) : 605-612, 2011
  pubmed

P.218 掲載の参考文献

• 14) Ho-Yeong Lim et al : Phase III study of GEMOX with or without erlotinib in unresectable, metastatic biliary tract carcinoma : multi-center trial in Korea. ASCO 2011 Abstract #LBA4032

• 15) Sharma A, Dwary AD, Mohanti BK et al : Best supportive care compared with chemotherapy for unresectable gall bladder cancer : a randomized controlled study. J Clin Oncol 28 (30) : 4581-4586, 2010
  pubmed

• 16) Sasaki T, Isayama H, Nakai Y et al : Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 65 (6) : 1101-1107, 2010
  pubmed

• 17) Yamashita Y, Taketomi A, Itoh S et al : Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers. Jpn J Clin Oncol 40 (1) : 24-28, 2010
  pubmed

• 18) 日本膵臓学会膵癌診療ガイドライン改訂委員会 編 : "科学的根拠に基づく膵癌診療ガイドライン (2009年版)", 金原出版, 東京, 2009

• 19) Moore MJ, Goldstein D, Hamm J et al ; National Cancer Institute of Canada Clinical Trials Group : Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer : a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25 (15) : 1960-1966, 2007

• 20) Ioka T et al : Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (Gem) in unresectable advanced pancreatic cancer in Japan and Taiwan : GEST study. ASCO 2011 Abstract #4007

• 21) Conroy T, Desseigne F, Ychou M et al : Groupe Tumeurs Digestives of Unicancer ; PRODIGE Intergroup : FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364 (19) : 1817-1825, 2011

P.219 掲載の参考文献

• 22) Vaccaro V, Sperduti I, Milella M : FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 365 (8) : 768-769, 2011
  pubmed

• 23) Neoptolemos JP, Stocken DD, Tudur Smith C et al : Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer : composite data from the ESPAC-1 and -3 (v1) trials. Br J Cancer 100 (2) : 246-250, 2009
  pubmed

• 24) Ishii H, Ueno H, Kosuge T et al : A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer : Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). J Clin Oncol 28 (Suppl) : e14625, 2010

• 25) Ueno H, Kosuge T, Matsuyama Y et al : A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer : Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 101 (6) : 908-915, 2009

P.220 掲載の参考文献

• 26) NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network, pancreatic adenocarcinoma http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

P.222 掲載の参考文献

• 1) Arita M, Bianchini F, Aliberti J et al : Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201 (5) : 713-722, 2005
  pubmed

• 2) Serhan CN, Yacoubian S, Yang R : Antiinflammatory and proresolving lipid mediators. Annu Rev Pathol 3 : 279-312, 2008
  pubmed

• 3) Serhan CN, Chiang N, Van Dyke TE : Resolving inflammation : dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (5) : 349-361, 2008
  pubmed

• 4) Schwab JM, Chiang N, Arita M et al : Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (7146) : 869-874, 2007
  pubmed

• 5) 社本智也, 松尾洋一, 竹山廣光 : 【臨床栄養トピックス 2012】 (Part-2) 臨床栄養学EPAとレゾルビン. 臨床栄養 121 (4) : 494-498, 2012

• 6) 鍋谷圭宏 : 【侵襲期栄養管理のトピックス】Immunonutritionの実際. 静脈経腸栄養 22 (3) : 289-296, 2007

• 7) Zhou M, Martindale RG : Immunemodulating enteral formulations : optimum components, appropriate patients, and controversial use of arginine in sepsis. Curr Gastroenterol Rep 9 (4) : 329-337, 2007
  pubmed

• 8) Consensus recommendations from the US summitt on immune-enhancing enteral therapy. JPEN J Parenter Enteral Nutr Apr ; 25 (2 Suppl) : S61-63, 2001

• 9) Weimann A, Braga M, Harsanyi L et al : ESPEN Guidelines on Enteral Nutrition : Surgery including organ transplantation. Clin Nutr 25 (2) : 224-244, 2006
  pubmed

P.223 掲載の参考文献

• 10) 鍋谷圭宏 : 【病態別経腸栄養法～病態別経腸栄養剤をいかに選択し, いかに使用するか? ～】エビデンスに基づく病態別経腸栄養法 病態別経腸栄養剤の選び方と使い方-周術期. 静脈経腸栄養 27 (2) : 643-650, 2012

• 11) 古川勝, 鈴木大, 相田俊 他 : 【肝胆膵疾患と栄養療法の最前線】胆道, 膵疾患と栄養 膵頭十二指腸切除術におけるimmunonutrition. 肝胆膵 63 (3) : 517-523, 2011

• 12) Vlug MS, Wind J, Hollmann MW et al : Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery : a randomized clinical trial (LAFA-study). Ann Surg 254 (6) : 868-875, 2011
  pubmed

• 13) Fearon KC, Ljungqvist O, Von Meyenfeldt M et al : Enhanced recovery after surgery : a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 24 (3) : 466-477, 2005
  pubmed

P.224 掲載の参考文献

• 14) 深柄和 : 【周術期の代謝栄養管理-ERASプロトコールを巡って-】ERASプロトコールにおける栄養管理. 栄養-評価と治療 29 (2) : 132-134, 2012

• 15) 深柄和 : 栄養からみたERAS. 外科と代謝・栄養 45 (5) : 163-167, 2011
  Medical*Online

• 16) Houston DK, Nicklas BJ, Ding J et al : Dietary protein intake is associated with lean mass change in older, community-dwelling adults : the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr 87 (1) : 150-155, 2008
  pubmed

• 17) Abbatecola AM, Paolisso G, Fattoretti P et al : Discovering pathways of sarcopenia in older adults : a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging 15 (10) : 890-895, 2011
  pubmed

P.225 掲載の参考文献

• 18) Forbes SC, Little JP, Candow DG : Exercise and nutritional interventions for improving aging muscle health. Endocrine 42 (1) : 29-38, 2012
  pubmed

• 19) van Loon LJ : Leucine as a pharmaconutrient in health and disease. Curr Opin Clin Nutr Metab Care 15 (1) : 71-77, 2012
  pubmed

• 20) Borsheim E, Bui QU, Tissier S et al : Effect of amino acid supplementation on muscle mass, strength and physical function in elderly. Clin Nutr 27 (2) : 189-195, 2008
  pubmed

P.226 掲載の参考文献

• 21) Awad S, Lobo DN : Metabolic conditioning to attenuate the adverse effects of perioperative fasting and improve patient outcomes. Curr Opin Clin Nutr Metab Care 15 (2) : 194-200, 2012
  pubmed

• 22) Kratzing C : Pre-operative nutrition and carbohydrate loading. Proc Nutr Soc 70 (3) : 311-315, 2011
  pubmed

• 23) Ljungqvist O : Jonathan E. Rhoads lecture 2011 : Insulin resistance and enhanced recovery after surgery. JPEN J Parenter Enteral Nutr 36 (4) : 389-398, 2012

P.227 掲載の参考文献

• 1) Gaynes RP, Culver DH, Horan TC et al : Surgical site infection (SSI) rates in the United States, 1992-1998 : the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 33 (Suppl2) : S69-S77, 2001

• 2) Gervaz P, Bandiera-Clerc C, Buchs NC et al : Scoring system to predict the risk of surgical-site infection after colorectal resection. Br J Surg 99 : 589-595, 2012
  pubmed

• 3) Pendlimari R, Cima RR, Wolff BG et al : Diagnoses influence surgical site infections (SSI) in colorectal surgery : a must consideration for SSI reporting programs? J Am Coll Surg 214 : 574-581, 2012
  pubmed

P.228 掲載の参考文献

• 4) 品川長夫 : 抗菌薬選択と使用の原則 周術期. "抗菌薬使用のガイドライン" 日本感染症学会, 日本化学療法学会編. 協和企画 pp50-53, 2005

• 5) 炭山嘉伸, 横山隆 : 消化器外科手術における抗生剤使用法をめぐって. 日消外会誌 27 : 2358-2367, 1994

• 6) Sumiyama Y, Kusachi S, Yoshida Y et al : Questionnaire on perioperative antibiotic therapy in 2003 : postoperative prophylaxis. Surg Today 36 : 107-113, 2006
  pubmed

• 7) Kobayashi M, Takesue Y, Kitagawa Y et al : Antimicrobial prophylaxis and colon preparation for colorectal surgery : results of a questionnaire survey of 721 certified institutions in Japan. Surg Today 41 : 1363-1369, 2011
  pubmed

• 8) Mohri Y, Tonouchi H, Kobayashi M et al : Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg 94 : 683-688, 2007
  pubmed

• 9) Imamura H, Kurokawa Y, Tsujinaka T et al : Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery : a phase 3, open-label, randomised controlled, non-inferiority trial. Lancet Infect Dis 12 : 381-387, 2012
  pubmed

• 10) Haga N, Ishida H, Ishiguro T et al : A prospective randomized study to assess the optimal duration of intravenous antimicrobial prophylaxis in elective gastric cancer surgery. Int Surg 97 : 169-176, 2012
  pubmed

P.229 掲載の参考文献

• 11) Gheorghe A, Calvert M, Pinkney TD et al : Systematic review of the clinical effectiveness of wound-edge protection devices in reducing surgical site infection in patients undergoing open abdominal surgery. Ann Surg 255 : 1017-1029, 2012
  pubmed

• 12) Edwards JP, Ho AL, Tee MC et al : Wound protectors reduce surgical site infection : a meta-analysis of randomized controlled trials. Ann Surg 256 : 53-59, 2012
  pubmed

• 13) van den Berghe G, Wouters P, Weekers F et al : Intensive insulin therapy in critically ill patients. N Engl J Med 345 : 1359-1367, 2001
  pubmed

• 14) The NICE-SUGAR Study Investigators : Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 : 1283-1297, 2009

• 15) Jackson RS, Amdur RL, White JC et al : Hyperglycemia is associated with increased risk of morbidity and mortality after colectomy for cancer. J Am Coll Surg 214 : 68-80, 2012

P.230 掲載の参考文献

• 16) Crolla RMPH, van der Laan L, Veen EJ et al : Reduction of surgical site infections after implementation of a bundle of care. PLOS One 7 : e44599, 2012
  pubmed

• 17) Murray BW, Cipher DJ, Pham T et al : The impact of surgical site infection on the development of incisional hernia and small bowel obstruction in colorectal surgery. Am J Surg 202 : 558-560, 2011

• 18) de Lissovoy G, Fraeman K, Hutchins V et al : Surgical site infection : Incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37 : 387-397, 2009
  pubmed

P.231 掲載の参考文献

• 19) Kusachi S, Kashimura N, Konishi T et al : Length of stay and cost for surgical site infection after abdominal and cardiac surgery in Japanese hospitals : multicenter surveillance. Surg Infect 13 : 257-265, 2012
  pubmed

• 20) Wick EC, Hirose K, Shore AD et al : Surgical site infections and cost in obese patients undergoing colorectal surgery. Arch Surg 146 : 1068-1072, 2011

P.232 掲載の参考文献

• 21) Solomkin JS, Mazuski JE, Bradley JS et al : Diagnosis and management of complicated intra-abdominal infection in adults and children : guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50 : 133-164, 2010

• 22) 三鴨廣繁, 竹末芳生, 草地信也 他 : 腹腔内感染症患者を対象としたtazobactam/piperacillinの臨床第III相試験. 日本化学療法学会雑誌 60 : 560-572, 2012

• 23) Teixeira PG, Sivrikoz E, Inaba K et al : Appendectomy timing : waiting until the next morning increases the risk of surgical site infections. Ann Surg 256 : 538-543, 2012
  pubmed

P.234 掲載の参考文献

• 1) Rosenberg SA : Cell transfer immunotherapy for metastatic solid cancer-- what clinicians need to know. Nat Rev Clin Oncol 8 (10) : 577-585, 2011
  pubmed

• 2) Dudley ME, Gross CA, Somerville RP et al : Randomized Selection Design Trial Evaluating CD8+ -Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma. J Clin Oncol 2013 (doi : 10.1200/JCO.2012.46.6441)

P.235 掲載の参考文献

• 3) Kaida M, Morita-Hoshi Y, Soeda A et al : Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer. J Immunother 34 (1) : 92-99, 2011
  pubmed

• 4) Okusaka T, Ueno M, Sato T et al : Possibility of immunotherapy for biliary tract cancer : how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial). J Hepatobiliary Pancreat Sci 19 (4) : 314-318, 2012

• 5) Bujas T, Marusic Z, Peric Balja M et al : MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma. Eur J Histochem 55 (1) : e7, 2011

• 6) Kakimi K, Isobe M, Uenaka A et al : A phase I study of vaccination with NYESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer 129 (12) : 2836-2846, 2011

P.236 掲載の参考文献

• 7) Sawada Y, Yoshikawa T, Nobuoka D et al : Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma : immunologic evidence and potential for improving overall survival. Clin Cancer Res 18 (13) : 3686-3696, 2012
  pubmed

• 8) Yoshikawa T, Nakatsugawa M, Suzuki S et al : HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells. Cancer Sci 102 (5) : 918-925, 2011
  pubmed

P.237 掲載の参考文献

• 9) Morse MA, Niedzwiecki D, Marshall JL et al : A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer. Ann Surg 2013 (doi : 10.1097/SLA.0b013e318292919e)

• 10) Hayashi H, Kurata T, Fujisaka Y et al : Phase I trial of OTS11101, an antiangiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. Cancer Sci 104 (1) : 98-104, 2013
  pubmed

• 11) Miyazawa M, Ohsawa R, Tsunoda T et al : Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. Cancer Sci 101 (2) : 433-439, 2010
  pubmed

• 12) Masuzawa T, Fujiwara Y, Okada K et al : Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer. Int J Oncol 2012 (doi : 10.3892/ijo.2012.1573)

• 13) Niethammer AG, Lubenau H, Mikus G et al : Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer. BMC Cancer 12 : 361, 2012
  pubmed

P.238 掲載の参考文献

• 1) Suda K, Ishida Y, Kawamura Y et al : Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position : technical report and short-term outcomes. World J Surg 36 : 1608-1616, 2012
  pubmed

• 2) Dunn DH, Johnson EM, Morphew JA et al : Robot-assisted transhiatal esophagectomy : a 3-year single-center experience. Dis Esophagus 26 : 159-166, 2013
  pubmed

• 3) Weksler B, Sharma P, Moudgill N et al : Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus 25 : 403-409, 2012
  pubmed

P.239 掲載の参考文献

• 4) Kim DJ, Hyung WJ, Lee CY et al : Thoracoscopic esophagectomy for esophageal cancer : feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg 139 : 53-59.e1, 2010

• 5) Woo Y, Hyung WJ, Pak KH et al : Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg 146 : 1086-1092, 2011
  pubmed

• 6) Wall J, Marescaux J : Robotic gastrectomy is safe and feasible, but real benefits remain elusive. Arch Surg 146 : 1092, 2011
  pubmed

• 7) Kim KM, An JY, Kim HI et al : Major early complications following open, laparoscopic and robotic gastrectomy. Br J Surg 99 : 1681-1687, 2012
  pubmed

P.240 掲載の参考文献

• 8) Xiong B, Ma L, Zhang C et al : Robotic versus laparoscopic gastrectomy for gastric cancer : a meta-analysis of short outcomes. Surg Oncol 21 : 274-280, 2012
  pubmed

• 9) Park JY, Jo MJ, Nam BH et al : Surgical stress after robot-assisted distal gastrectomy and its economic implications. Br J Surg 99 : 1554-1561, 2012
  pubmed

• 10) Yoon HM, Kim YW, Lee JH et al : Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer. Surg Endosc 26 : 1377-1381, 2012
  pubmed

• 11) Uyama I, Kanaya S, Ishida Y et al : Novel integrated robotic approach for suprapancreatic D2 nodal dissection for treating gastric cancer : technique and initial experience. World J Surg 36 : 331-337, 2012
  pubmed

• 12) Park SS, Kim MC, Park MS et al : Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons. Surg Endosc 26 : 60-67, 2012
  pubmed

P.241 掲載の参考文献

• 13) Memon S, Heriot AG, Murphy DG et al : Robotic versus laparoscopic proctectomy for rectal cancer : a meta-analysis. Ann Surg Oncol 19 : 2095-2101, 2012

• 14) Park SY, Choi GS, Park JS et al : Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal cancer : a retrospective comparison with conventional laparoscopy. Surg Endosc. 27 : 48-55, 2013
  pubmed

• 15) Park JS, Choi GS, Lim KH et al : Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer : initial clinical experience. Surg Endosc 25 : 3322-3329, 2011
  pubmed

P.242 掲載の参考文献

• 16) Park JS, Choi GS, Park SY et al : Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg 99 : 1219-1226, 2012
  pubmed

• 17) Giulianotti PC, Sbrana F, Coratti A et al : Totally robotic right hepatectomy : surgical technique and outcomes. Arch Surg 146 : 844-850, 2011
  pubmed

• 18) Choi GH, Choi SH, Kim SH et al : Robotic liver resection : technique and results of 30 consecutive procedures. Surg Endosc 26 : 2247-2258, 2012
  pubmed

• 19) Ho CM, Wakabayashi G, Nitta H et al : Systematic review of robotic liver resection. Surg Endosc 2012, in press

• 20) Daouadi M, Zureikat AH, Zenati MS et al : Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg 257 : 128-132, 2013

P.243 掲載の参考文献

• 21) Hwang HK, Kang CM, Chung YE et al : Robot-assisted spleen-preserving distal pancreatectomy : a single surgeon's experiences and proposal of clinical application. Surg Endosc. 2012, in press

• 22) Zeh HJ, Zureikat AH, Secrest A et al : Outcomes after robot-assisted pancreaticoduodenectomy for periampullary lesions. Ann Surg Oncol 19 : 864-870, 2012

P.244 掲載の参考文献

• 1) Sano K, Ichikawa T, Motosugi U et al : Imaging study of early hepatocellular carcinoma : usefulness of gadoxetic acidenhanced MR imaging. Radiology 261 (3) : 834-844, 2011
  pubmed

• 2) Kitao A, Matsui O, Yoneda N et al : The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis : correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21 (10) : 2056-2066, 2011
  pubmed

• 3) Golfieri R, Grazioli L, Orlando E et al : Which is the best MRI marker of malignancy for atypical cirrhotic nodules : Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. J Magn Reson Imaging, 2012 (doi : 10.1002/jmri.23685)
  pubmed

P.245 掲載の参考文献

• 4) Kim YK, Lee WJ, Park MJ et al : Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acidenhanced MR images in patients with cirrhosis : potential of DW imaging in predicting progression to hypervascular HCC. Radiology 265 (1) : 104-114, 2012
  pubmed

• 5) Park MJ, Kim YK, Lee MW et al : Small hepatocellular carcinomas : improved sensitivity by combining gadoxetic acidenhanced and diffusion-weighted MR imaging patterns. Radiology 264 (3) : 761-770, 2012
  pubmed

• 6) Kunishi Y, Numata K, Morimoto M et al : Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. AJR Am J Roentgenol 198 (1) : 106-114, 2012
  pubmed

• 7) Kim YK, Lee MW, Lee WJ et al : Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acidenhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≦ 1.5 cm in diameter). Invest Radiol 47 (3) : 159-166, 2012

• 8) Grazioli L, Bondioni MP, Haradome H et al : Hepatocellular adenoma and focal nodular hyperplasia : value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262 (2) : 520-529, 2012
  pubmed

• 9) van Aalten SM, Thomeer MG, Terkivatan T et al : Hepatocellular adenomas : correlation of MR imaging findings with pathologic subtype classification. Radiology 261 (1) : 172-181, 2011
  pubmed

• 10) Shim JH, Lee HC, Kim SO et al : Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models. Radiology 262 (2) : 708-718, 2012
  pubmed

P.246 掲載の参考文献

• 11) Motosugi U, Ichikawa T, Muhi A et al : Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocytephase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease. Invest Radiol 47 (10) : 566-570, 2012

• 12) Noworolski SM, Lam MM, Merriman RB et al : Liver steatosis : concordance of MR imaging and MR spectroscopic data with histologic grade. Radiology 264 (1) : 88-96, 2012

• 13) Ouwerkerk R, Pettigrew RI, Gharib AM : Liver metabolite concentrations measured with 1H MR spectroscopy. Radiology 265 (2) : 565-575, 2012
  pubmed

• 14) Nakaura T, Nakamura S, Maruyama N et al : Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT : effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality. Radiology 264 (2) : 445-454, 2012
  pubmed

• 15) Lee KH, Lee JM, Moon SK et al : Attenuation-based automatic tube voltage selection and tube current modulation for dose reduction at contrast-enhanced liver CT. Radiology 265 (2) : 437-447, 2012
  pubmed

• 16) Joe E, Kim SH, Lee KB et al : Feasibility and accuracy of dual-source dual-energy CT for noninvasive determination of hepatic iron accumulation. Radiology 262 (1) : 126-135, 2012
  pubmed

P.247 掲載の参考文献

• 17) Sasaki R, Kondo T, Oda T et al : Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma. Am J Surg 202 (4) : 441-448, 2011
  pubmed

• 18) Tranchart H, Gaujoux S, Rebours V et al : Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg 256 (1) : 139-145, 2012
  pubmed

• 19) Glatard AS, Hillaire S, d'Assignies G et al : Obliterative portal venopathy : findings at CT imaging. Radiology 263 (3) : 741-750, 2012
  pubmed

• 20) Hirooka M, Ochi H, Koizumi Y et al : Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology 261 (3) : 960-968, 2011
  pubmed

• 21) Colecchia A, Montrone L, Scaioli E et al : Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143 (3) : 646-654, 2012
  pubmed

• 22) Zhu X, Wang LC, Chen EQ et al : Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Digestive diseases and sciences. 2011 ; 56 (9) : 2742-9

• 23) Arda K, Ciledag N, Aktas E et al : Quantitative assessment of normal soft-tissue elasticity using shear-wave ultrasound elastography. AJR Am J Roentgenol 197 (3) : 532-536, 2011
  pubmed

• 24) Anaye A, Perrenoud G, Rognin N et al : Differentiation of focal liver lesions : usefulness of parametric imaging with contrast-enhanced US. Radiology 261 (1) : 300-310, 2011
  pubmed

• 25) Laumonier H, Cailliez H, Balabaud C et al : Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma : correlation with MRI findings. AJR Am J Roentgenol 199 (2) : 341-348, 2012
  pubmed

P.248 掲載の参考文献

• 26) Takahashi M, Hasegawa K, Arita J et al : Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases. Br J Surg 99 (9) : 1271-1277, 2012
  pubmed

• 27) Arita J, Takahashi M, Hata S et al : Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg 254 (6) : 992-999, 2011
  pubmed

• 28) Lan BY, Kwee SA, Wong LL : Positron emission tomography in hepatobiliary and pancreatic malignancies : a review. Am J Surg 204 (2) : 232-241, 2012
  pubmed

• 29) Kim BK, Kang WJ, Kim JK et al : 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117 (20) : 4779-4787, 2011
  pubmed

• 30) Pedrazzoli S, Sperti C, Pasquali C et al : Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 254 (6) : 971-976, 2011
  pubmed

• 31) Venkatesan AM, Kadoury S, Abi-Jaoudeh N et al : Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology 260 (3) : 848-856, 2011
  pubmed